var title_f38_50_39712="Fecal incontinence ACG";
var content_f38_50_39712=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F69758&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F69758&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 580px\">",
"   <div class=\"ttl\">",
"    Algorithmic approach for the evaluation and management of patients with fecal incontinence",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 560px; height: 626px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rao, SS. Diagnosis and management of fecal incontinence. Am J Gastroenterol 2004; 99:1585. Copyright &copy; 2004 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_50_39712=[""].join("\n");
var outline_f38_50_39712=null;
var title_f38_50_39713="M-mode subcostal view IVC";
var content_f38_50_39713=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F68450&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F68450&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    M-mode echocardiogram from the subcostal position showing variation in IVC size with respiration",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 253px; height: 342px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The inferior vena cave (IVC) can be imaged by aligning the ultrasound beam plane parallel to the long axis of the body and placing the transducer subcostally just to the right of the midline (panel A); the white line running through the image is the beam plane used to generate the M-modes of the inferior vena cave (panels B and C). In panel B, the IVC is dilated and its collapse or narrowing in response to respiration blunted; the hepatic veins (HV) are also dilated. In panel C, the IVC is of normal size and responds normally to respiration. When the IV (RA) pressure is usually around 20 mmHg or greater; the RA pressure is usually 0 to 5 mmHg when the IVC diameter is small and good respiratory response is seen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_50_39713=[""].join("\n");
var outline_f38_50_39713=null;
var title_f38_50_39714="Algorithm diagnosis adult knee pain";
var content_f38_50_39714=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F62865&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F62865&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 621px\">",
"   <div class=\"ttl\">",
"    Algorithm for diagnosis of knee pain in adults",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 601px; height: 713px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_50_39714=[""].join("\n");
var outline_f38_50_39714=null;
var title_f38_50_39715="CRS NP CR rhinoscopy";
var content_f38_50_39715=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F57710&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F57710&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Radiographic and rhinoscopic features of with CRS with NP",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 253px; height: 468px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Coronal sinus CT scan showing evidence of prior functional endoscopic sinus surgery with persistence of polypoid mucosal thickening in both maxillary sinuses and polypoid opacification of the anterior ethmoid sinuses. B) Rhinoscopic photograph showing the typical appearance of polypoid regrowth in the left anterior ethmoid region.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Daniel Hamilos, MD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_50_39715=[""].join("\n");
var outline_f38_50_39715=null;
var title_f38_50_39716="VSD closure device 2D and color";
var content_f38_50_39716=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1181px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/72636/VSD_clos_devic_color_movie.mp4?title=VSD+closure+device+2D+and+color\" style=\"width:496px;height:400px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 565px\">",
"   <div class=\"ttl\">",
"    VSD closure device 2D and color",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 545px; height: 345px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     Paired mid-esophageal apical four-chamber movie clips&nbsp;with and without color Doppler imaging from intraoperative transesophageal echocardiogram (TEE). The images show a relatively empty heart on cardiopulmonary bypass during intraoperative placement of an Amplatzer muscular VSD device. The device has been positioned using a perventricular approach, introducing the sheath and later the device through the right ventricular wall using TEE guidance. The device&nbsp;is well seated on the septum and remains attached to the delivery cable at this point in the procedure. Color Doppler imaging shows no significant residual shunting in the region of the VSD closure device.",
"    </p>",
"    <div class=\"footnotes\">",
"     RA: right atrium; LA: left atrium; IVS: intraventricular septum; RV: right ventricle; LV: left ventricle; small arrows: Amplatzer VSD occluder device; large arrow: delivery cable.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_50_39716=[""].join("\n");
var outline_f38_50_39716=null;
var title_f38_50_39717="Dissection along the latissimus dorsi muscle";
var content_f38_50_39717=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F64682&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F64682&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dissection along the latissimus dorsi muscle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 418px; height: 383px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The pectoralis muscle has been exposed and retracted medially, and dissection is carried out on the anterior surface of the latissimus dorsi muscle as it courses superiorly.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Harris JR, Lippman ME, MorrowM, Osborne CK. Diseases of the Breast, Third Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_50_39717=[""].join("\n");
var outline_f38_50_39717=null;
var title_f38_50_39718="Primary sclerosing cholangitis - medium power";
var content_f38_50_39718=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F65071&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F65071&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Primary sclerosing cholangitis (medium power, Masson trichrome)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 284px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    There is a necrotic bile duct at the center of an onion skin lesion, a finding consistent with stage II PSC. The biopsy is from a 39-year-old man with PSC and ulcerative colitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_50_39718=[""].join("\n");
var outline_f38_50_39718=null;
var title_f38_50_39719="Diagnosis and treatment of glucose-6-phosphate dehydrogenase deficiency";
var content_f38_50_39719=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnosis and treatment of glucose-6-phosphate dehydrogenase deficiency",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/50/39719/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/50/39719/contributors\">",
"     Bertil Glader, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/50/39719/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/50/39719/contributors\">",
"     Stanley L Schrier, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/50/39719/contributors\">",
"     Donald H Mahoney, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/50/39719/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/50/39719/contributors\">",
"     Stephen A Landaw, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/50/39719/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucose 6-phosphate dehydrogenase (G6PD) deficiency, an X-linked disorder, is the most common enzymatic disorder of red blood cells in humans, affecting 200 to 400 million people worldwide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The clinical expression of G6PD deficiency encompasses a spectrum of hemolytic syndromes. While affected patients are usually asymptomatic, some have episodic anemia while a few have chronic hemolysis. With the most prevalent G6PD variants (G6PD A- and G6PD Mediterranean), severe hemolysis is induced by the sudden destruction of older, more deficient erythrocytes after exposure to drugs having a high redox potential (including the antimalarial drug",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/59/38837?source=see_link\">",
"     primaquine",
"    </a>",
"    and certain sulfa drugs) or to fava beans, selected infections, or metabolic abnormalities. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/25/4505?source=see_link\">",
"     \"Clinical manifestations of glucose-6-phosphate dehydrogenase deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The likelihood of developing hemolysis and the severity of disease are determined by the magnitude of the enzyme deficiency, which in turn is determined by biochemical characteristics of the G6PD variant. The World Health Organization has classified the different G6PD variants according to the magnitude of the enzyme deficiency and the severity of hemolysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/3\">",
"     3",
"    </a>",
"    ]. Classes IV and V are of no clinical significance. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/62/13289?source=see_link&amp;anchor=H5#H5\">",
"     \"Genetics and pathophysiology of glucose-6-phosphate dehydrogenase deficiency\", section on 'Classification of G6PD variants'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Class I variants have severe enzyme deficiency (less than 10 percent of normal) and have chronic hemolytic anemia",
"     </li>",
"     <li>",
"      Class II variants also have severe enzyme deficiency, but there is usually only intermittent hemolysis",
"     </li>",
"     <li>",
"      Class III variants have moderate enzyme deficiency (10 to 60 percent of normal) with intermittent hemolysis usually associated with infection or drugs",
"     </li>",
"     <li>",
"      Class IV variants have no enzyme deficiency or hemolysis",
"     </li>",
"     <li>",
"      Class V variants have increased enzyme activity",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10276749\">",
"    <span class=\"h1\">",
"     EXPRESSION IN MALES AND FEMALES",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Males",
"      </strong>",
"      , who have only one copy of the X chromosome, are either normal or hemizygous for the variant G6PD gene. Thus, G6PD deficiency is expressed in males carrying a variant gene on their X chromosome that produces sufficient enzyme deficiency to lead to symptoms. All of the red cells in affected males are vulnerable to hemolysis.",
"     </li>",
"     <li>",
"      <strong>",
"       Females",
"      </strong>",
"      , who have two copies of the X chromosome, are either normal, heterozygous, or homozygous for the variant gene.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <strong>",
"       Heterozygous females",
"      </strong>",
"      are usually clinically normal. However, their mean red blood cell enzyme activity may be normal, moderately reduced, or grossly deficient depending upon the degree of X chromosome inactivation (lyonization) and the degree to which the abnormal G6PD variant is expressed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/4,5\">",
"       4,5",
"      </a>",
"      ]. A female with 50 percent normal G6PD activity, due to inactivation of one X chromosome in each cell via lyonization, has 50 percent normal red cells and 50 percent G6PD-deficient red cells. The deficient cells are as vulnerable to hemolysis as the enzyme-deficient red blood cells in males. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/44/43717?source=see_link&amp;anchor=H2#H2\">",
"       \"Glossary of genetic terms\", section on 'Glossary'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Homozygous females",
"      </strong>",
"      are as severely affected clinically as hemizygous males. All of their red cells are vulnerable to hemolysis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Considering the diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;G6PD deficiency should be considered in the differential diagnosis of any nonimmune hemolytic anemia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/3/18489?source=see_link\">",
"     \"Approach to the diagnosis of hemolytic anemia in the adult\"",
"    </a>",
"    .) In most patients, the anemia is first recognized during or after an infectious illness, after exposure to one of a number of drugs or chemicals (",
"    <a class=\"graphic graphic_table graphicRef74254 \" href=\"mobipreview.htm?19/22/19821\">",
"     table 1",
"    </a>",
"    ), or during an episode of diabetic ketoacidosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/25/4505?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical manifestations of glucose-6-phosphate dehydrogenase deficiency\", section on 'Acute hemolytic anemia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the newborn period, G6PD deficiency should also be considered in any infant with unexplained hyperbilirubinemia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/3/39992?source=see_link&amp;anchor=H7#H7\">",
"     \"Pathogenesis and etiology of unconjugated hyperbilirubinemia in the newborn\", section on 'Causes of hyperbilirubinemia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Clinical and laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical and hematologic findings are those of any hemolytic anemia and reflect the degree of hemolysis. Oxidant injury to hemoglobin leads first to the formation of methemoglobin and then to sulfhemoglobin or denatured globin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/62/13289?source=see_link&amp;anchor=H9#H9\">",
"     \"Genetics and pathophysiology of glucose-6-phosphate dehydrogenase deficiency\", section on 'Pathophysiology of G6PD deficiency'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The oxidative denaturation of hemoglobin also leads to the crosslinking of the denatured globin to the red cell membrane; as a result, hemoglobin is no longer free to flow in the cytosol, producing puddling of hemoglobin to one side of the cell with an adjacent membrane-bound clear zone [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/7\">",
"       7",
"      </a>",
"      ]. On the peripheral blood smear, these changes are manifest as &ldquo;bite cells&rdquo; (also called hemiblister cells, cross bonded cells, and eccentrocytes) (",
"      <a class=\"graphic graphic_picture graphicRef73790 \" href=\"mobipreview.htm?25/28/26054\">",
"       picture 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/8-11\">",
"       8-11",
"      </a>",
"      ]. Bite cells were thought to be caused by phagocytic removal of Heinz bodies by the splenic monocyte-macrophage system. However, the bite-like or blister-like deformities may simply reflect the unstained nonhemoglobin-containing portion of the cell membrane [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Brilliant cresyl blue supravital stains of the peripheral blood may reveal the denatured globin as Heinz bodies during hemolytic episodes (",
"      <a class=\"graphic graphic_picture graphicRef73790 \" href=\"mobipreview.htm?25/28/26054\">",
"       picture 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Methodology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The method used to establish the diagnosis of G6PD deficiency is based upon the normal function of the enzyme. G6PD catalyzes the initial step in the hexose monophosphate (HMP or pentose phosphate) shunt, which is the only red cell source of reduced nicotinamide adenine dinucleotide phosphate (NADPH), a cofactor important in glutathione metabolism (",
"    <a class=\"graphic graphic_figure graphicRef77081 \" href=\"mobipreview.htm?18/40/19085\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The diagnosis of G6PD deficiency is made by adding a measured amount of red cell hemolysate to an assay mixture that contains substrate (glucose-6-phosphate) and cofactor (NADP); the rate of NADPH generation is measured spectrophotometrically [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Normal values differ according to the methodology employed, and are directly related to the temperature (25&deg; or 37&deg;) at which the assays are performed. Typical values are the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <strong>",
"       Normal range at 25&deg;C",
"      </strong>",
"      : 5.5 to 8.8",
"      <span class=\"nowrap\">",
"       Units/gram",
"      </span>",
"      of hemoglobin",
"     </li>",
"     <li>",
"      <strong>",
"       Normal range at 37&deg;C",
"      </strong>",
"      : 8.0 to 13.46",
"      <span class=\"nowrap\">",
"       Units/gram",
"      </span>",
"      of hemoglobin",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Levels of G6PD are higher in the newborn than they are in the adult [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/5\">",
"     5",
"    </a>",
"    ]. When high levels are seen in older patients it invariably reflects the presence of a young red blood cell population with reticulocytosis.",
"   </p>",
"   <p>",
"    As mentioned above, females carrying one copy of the abnormal G6PD gene may have enzyme levels that are normal, moderately reduced, or grossly deficient. Accordingly, accurate identification of heterozygous females may not be possible unless DNA analysis for the abnormal gene is performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10276749\">",
"     'Expression in males and females'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    There are also a number of screening tests that are available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/14\">",
"     14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The fluorescent spot test is the simplest, most reliable, and most sensitive of the G6PD screening tests [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/15,16\">",
"       15,16",
"      </a>",
"      ]. It is based upon the fluorescence of NADPH after glucose-6-phosphate and NADP are added to a hemolysate of test red cells.",
"     </li>",
"     <li>",
"      Other screening tests estimate NADPH generation indirectly by measuring the transfer of hydrogen ions from NADPH to an acceptor. In the methemoglobin reduction test, for example,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?1/7/1143?source=see_link\">",
"       methylene blue",
"      </a>",
"      is used to transfer hydrogen from NADPH to methemoglobin, thereby promoting its reduction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/14,17\">",
"       14,17",
"      </a>",
"      ]. When combined with a technique for the elution of methemoglobin from intact cells, this test can detect relative G6PD sufficiency in individual red cells; this permits detection of the carrier state with approximately 75 percent accuracy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As an aside, the relationship between",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/7/1143?source=see_link\">",
"     methylene blue",
"    </a>",
"    and G6PD is also important in patients with acute methemoglobinemia. Methylene blue is an effective treatment for methemoglobinemia since it can reduce methemoglobin to hemoglobin. However, since this reaction is dependent upon NADPH generated by G6PD, methylene blue may be ineffective in the treatment of methemoglobinemia in individuals with G6PD deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/19\">",
"     19",
"    </a>",
"    ]. Furthermore, methylene blue is potentially dangerous in these patients since it has oxidant potential and may produce hemolysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/33/8729?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of methemoglobinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     False negative results",
"    </span>",
"    &nbsp;&mdash;&nbsp;A potential concern with any of the tests used to detect G6PD deficiency is the existence of false-negative reactions, which occur if the most severely deficient red cells have already been removed from the circulation via hemolysis. This problem is usually not important when testing male Caucasians, but is a concern in some Caucasian females and blacks of both sexes, especially during the reticulocytosis following acute hemolysis. When a false negative test is suspected, the best approach is to re-evaluate the patient three months after the hemolytic episode, a time at which the red cell mass will have been repopulated with red cells of all ages.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     TREATMENT AND PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of the patient with G6PD deficiency is determined by the clinical syndrome with which it is associated. Patients with acute, acquired hemolysis can develop a significant fall in hemoglobin concentration. Among the major variants, acute hemolysis occurs more commonly with G6PD Mediterranean (a class II variant with a half-life measured in hours) than with G6PD A- (a class III variant with a half-life of 13 days [normal 62 days]). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/62/13289?source=see_link&amp;anchor=H5#H5\">",
"     \"Genetics and pathophysiology of glucose-6-phosphate dehydrogenase deficiency\", section on 'Classification of G6PD variants'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    All affected individuals should, whenever possible, avoid exposure to drugs known to trigger hemolysis (",
"    <a class=\"graphic graphic_table graphicRef74254 \" href=\"mobipreview.htm?19/22/19821\">",
"     table 1",
"    </a>",
"    ). In addition, pregnant and nursing women who are heterozygous for G6PD deficiency should avoid drugs with oxidant potential, because some of these drugs gain access to the fetal circulation and to breast milk. It has also been suggested that affected individuals should avoid ingestion of fava beans, which can cause hemolysis in some, but not all, subjects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, because the degree of hemolysis is typically mild, one of the drugs known to trigger hemolysis may be given to individuals with Class III G6PD variants if there is an important indication for its use. As an example,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/59/38837?source=see_link\">",
"     primaquine",
"    </a>",
"    has been safely given to individuals with the G6PD A- variant as long as a low dose is used (15",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    or 45 mg once or twice weekly) and the blood count is monitored closely [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/21\">",
"     21",
"    </a>",
"    ]. The mild anemia that may ensue is corrected by the compensatory increase in erythropoietin secretion and does not recur unless the dose of the drug is escalated. Transfusions are required only if the hemolytic episodes occur in the presence of impaired erythropoiesis.",
"   </p>",
"   <p>",
"    More active therapy may be required in patients with chronic nonspherocytic hemolytic anemia due to class I G6PD variants. As with other syndromes resulting from G6PD deficiency, patients with class I variants should avoid drugs capable of increasing the degree of hemolysis (",
"    <a class=\"graphic graphic_table graphicRef74254 \" href=\"mobipreview.htm?19/22/19821\">",
"     table 1",
"    </a>",
"    ). Other therapies have been tried, such as splenectomy and, because of its antioxidant activity, vitamin E, with occasional reports of modest improvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. However, these approaches are generally without benefit. Splenectomy, although occasionally bringing about a modest improvement in hemoglobin concentration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/22\">",
"     22",
"    </a>",
"    ], is generally without benefit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/25-27\">",
"     25-27",
"    </a>",
"    ]. Gene transfer is theoretically curative for patients with severe disease, although such approaches are still at the preclinical level [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Subjects with chronic hemolytic anemia (eg, hereditary spherocytosis, paroxysmal nocturnal hemoglobinuria, sickle cell anemia) are often given",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    supplementation in order to avoid folic acid deficiency secondary to increased vitamin requirements from the ensuing increase in erythropoietic activity. Doses in the range of 1",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    have been employed. Folate supplementation may be useful in Class I G6PD variants, but is not needed in the most common Class II and III variants where there is only intermittent hemolysis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Neonatal jaundice",
"    </span>",
"    &nbsp;&mdash;&nbsp;A serious complication of G6PD deficiency is neonatal jaundice occurring during the first week of life, since bilirubin-induced neurotoxicity that can result in permanent neurologic sequelae (kernicterus) can occur in populations in which class II variants are common. Phototherapy can be used to lower the serum bilirubin concentration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Phototherapy acts by converting a portion of bilirubin IX-alfa-ZZ into its geometric and structural isomers, which are then excreted in the bile without the prerequisite for conjugation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/18/27943?source=see_link\">",
"     \"Bilirubin metabolism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Exchange transfusion is necessary in such infants if the serum bilirubin concentration exceeds 20",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (342",
"    <span class=\"nowrap\">",
"     micromol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/59/21434?source=see_link&amp;anchor=H19#H19\">",
"     \"Treatment of unconjugated hyperbilirubinemia in term and late preterm infants\", section on 'Exchange transfusion'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The role of prophylactic",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/40/29321?source=see_link\">",
"     phenobarbital",
"    </a>",
"    in reducing neonatal jaundice and the need for intervention in infants with G6PD deficiency is unclear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. In one randomized controlled study of 56 neonates identified with G6PD deficiency by cord blood screening, there was",
"    <strong>",
"     no",
"    </strong>",
"    difference in the rate of phototherapy or exchange transfusions between patients who received prophylactic phenobarbital and those who did not [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/34\">",
"     34",
"    </a>",
"    ]. Prenatal administration of phenobarbital has been observed to adversely affect cognitive development and reproduction. As a result, phenobarbital is",
"    <strong>",
"     not",
"    </strong>",
"    used to treat indirect hyperbilirubinemia in normal term infants. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/59/21434?source=see_link&amp;anchor=H29#H29\">",
"     \"Treatment of unconjugated hyperbilirubinemia in term and late preterm infants\", section on 'Phenobarbital'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is of interest that most cases of neonatal hyperbilirubinemia occur in the absence of obvious exposure to external oxidants. Furthermore, there is often no evidence of increased red cell breakdown in neonates who develop hyperbilirubinemia compared with deficient neonates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. These observations suggest an important role for impaired hepatic clearance of bilirubin. In support of this hypothesis is the observation that neonates with G6PD Mediterranean have a partial defect in bilirubin glucuronide conjugation similar to that seen in Gilbert's disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Screening for G6PD deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Generalized screening for G6PD deficiency, including routine blood bank screening, is not performed and molecular techniques for prenatal diagnosis have not been developed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/38\">",
"     38",
"    </a>",
"    ] because most common variants that cause acquired hemolytic anemia pose little health hazard. The class I G6PD variants associated with chronic hemolysis are so rare that screening is impractical. However, it could be argued that certain Mediterranean populations, especially Kurdish Jewish males, in whom the prevalence of G6PD deficiency is 60 to 70 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/39\">",
"     39",
"    </a>",
"    ], might benefit from detection of G6PD deficiency so they can avoid obvious oxidant exposures.",
"   </p>",
"   <p>",
"    Routine screening of blood donors is not performed since there are generally no deleterious consequences in recipients of G6PD-deficient blood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/40\">",
"     40",
"    </a>",
"    ]. There are, however, some problems that can occur:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients receiving G6PD Mediterranean blood may have transient elevations in serum bilirubin and lactate dehydrogenase that can be confused with a delayed transfusion reaction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/41\">",
"       41",
"      </a>",
"      ]. It is possible that, in areas with a high prevalence of G6PD Mediterranean, a more marked degree of hemolysis could occur after transfusion of several units of deficient blood.",
"     </li>",
"     <li>",
"      Transfusion of G6PD deficient red cells to premature infants has been associated with hemolysis and severe hyperbilirubinemia requiring exchange transfusion [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/42\">",
"       42",
"      </a>",
"      ]. In addition, massive intravascular hemolysis has occurred after an exchange transfusion with G6PD deficient blood [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because of the latter observations, it has been recommended that, in areas in which G6PD deficiency with class II variants is common, donor blood should be screened for the enzyme deficiency before transfusing premature infants or performing neonatal exchange transfusion. However, this recommendation is not standard blood banking practice.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     ADDITIONAL INFORMATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Associazione Italiana Favismo - Deficit di G6PD (G6PD Deficiency favism association) maintains a website",
"    <a class=\"external\" href=\"file://g6pd.org/favism/english/index.mvc\">",
"     file://g6pd.org/favism/english/index.mvc",
"    </a>",
"    that gives patients, families, and clinicians additional information concerning this disorder, and maintains a listing of medications that are \"unsafe to take\" as well as those that are considered \"low-risk drugs\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39719/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?12/41/12946?source=see_link\">",
"       \"Patient information: Glucose-6-phosphate dehydrogenase deficiency (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21132140\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21132148\">",
"    <span class=\"h2\">",
"     When to suspect G6PD deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucose-6-phosphate dehydrogenase (G6PD) deficiency should be suspected in any subject with an episode of non-immune hemolytic anemia, especially if occurring after drug ingestion, exposure to fava beans, or associated with an infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/25/4505?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical manifestations of glucose-6-phosphate dehydrogenase deficiency\", section on 'Acute hemolytic anemia'",
"    </a>",
"    .) In the newborn period, G6PD deficiency should be considered in any infant with unexplained hyperbilirubinemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21132167\">",
"    <span class=\"h2\">",
"     How to diagnose G6PD deficiency",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      G6PD deficiency is diagnosed by finding decreased activity of this enzyme in red cells. A number of screening tests are available for this purpose. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Methodology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      False-negative results on screening tests can occur immediately following an episode of hemolysis. Retesting at a later date should be performed if this is the case. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'False negative results'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21132229\">",
"    <span class=\"h2\">",
"     Treatment of hemolytic episodes",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Episodes of hemolysis in patients with G6PD deficiency are usually self-limited. Transfusion with packed red cells may be necessary in cases of severe hemolysis and symptomatic anemia.",
"     </li>",
"     <li>",
"      There is no specific treatment for subjects with Class I variants who have chronic hemolysis. Avoidance of oxidant agents is the most prudent. Administration of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/61/9174?source=see_link\">",
"       folic acid",
"      </a>",
"      in a dose of 1",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      may prevent worsening of anemia due to folate depletion in this group of patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21132250\">",
"    <span class=\"h2\">",
"     Prevention of future hemolytic episodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subjects with G6PD deficiency should avoid drugs and chemicals with oxidant potential. A partial list of safe and unsafe drugs is given in the table (",
"    <a class=\"graphic graphic_table graphicRef74254 \" href=\"mobipreview.htm?19/22/19821\">",
"     table 1",
"    </a>",
"    ). A more complete list of safe and unsafe agents is available through the Associazione Italiana Favismo &ndash; Deficit di G6PD. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Additional information'",
"    </a>",
"    above.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/1\">",
"      Mason PJ, Bautista JM, Gilsanz F. G6PD deficiency: the genotype-phenotype association. Blood Rev 2007; 21:267.",
"     </a>",
"    </li>",
"    <li>",
"     Glader B. Hereditary hemolytic anemias due to red blood cell enzyme disorders. In: Wintrobe's Clinical Hematology, 12th ed, Greer JP, Foerster J, Rodgers GM, et al. (Eds), Philadelphia 2009. p.933.",
"    </li>",
"    <li>",
"     Beutler E. The molecular biology of enzymes of erythrocyte metabolism. In: The Molecular Basis of Blood Disease, Stamatoyannopoulos G, Nienhus AW, Majerus PW, et al. (Eds), WB Saunders, Philadelphia 1993.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/4\">",
"      Hsia YE, Miyakawa F, Baltazar J, et al. Frequency of glucose-6-phosphate dehydrogenase (G6PD) mutations in Chinese, Filipinos, and Laotians from Hawaii. Hum Genet 1993; 92:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/5\">",
"      Algur N, Avraham I, Hammerman C, Kaplan M. Quantitative neonatal glucose-6-phosphate dehydrogenase screening: distribution, reference values, and classification by phenotype. J Pediatr 2012; 161:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/6\">",
"      Jacob HS. Mechanisms of Heinz body formation and attachment to red cell membrane. Semin Hematol 1970; 7:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/7\">",
"      Fischer TM, Meloni T, Pescarmona GP, Arese P. Membrane cross bonding in red cells in favic crisis: a missing link in the mechanism of extravascular haemolysis. Br J Haematol 1985; 59:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/8\">",
"      Arese P, De Flora A. Pathophysiology of hemolysis in glucose-6-phosphate dehydrogenase deficiency. Semin Hematol 1990; 27:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/9\">",
"      Greenberg MS. Heinz body hemolytic animea. \"Bite cells\" -a clue to diagnosis. Arch Intern Med 1976; 136:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/10\">",
"      Yoo D, Lessin LS. Drug-associated \"bite cell\" hemolytic anemia. Am J Med 1992; 92:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/11\">",
"      Bain BJ. Diagnosis from the blood smear. N Engl J Med 2005; 353:498.",
"     </a>",
"    </li>",
"    <li>",
"     Beutler E. Red cell metabolism. In: A Manual of Biochemical Methods, 3rd ed, Grune and Stratton, New York 1984.",
"    </li>",
"    <li>",
"     Motulsky AG, Yoshida A. Methods for the study of red cell, glucose-6-phosphate dehydrogenase. In: Biochemical Methods in Red Cell Genetics, Yunis JJ (Ed), Academic Press, New York 1969.",
"    </li>",
"    <li>",
"     WHO Scientific Group. Standardization of procedures for the study of glucose-6-phosphate dehydrogenase. WHO Tech Rep Ser 366, Geneva 1967.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/15\">",
"      Beutler E, Mitchell M. Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency. Blood 1968; 32:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/16\">",
"      Fairbanks VF, Beutler E. A simple method for detection of erythrocyte glucose-6-phosphate dehydrogenase (G-6-PD spot test). Blood 1962; 20:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/17\">",
"      BREWER GJ, TARLOV AR, ALVING AS. The methemoglobin reduction test for primaquine-type sensitivity of erythrocytes. A simplified procedure for detecting a specific hypersusceptibility to drug hemolysis. JAMA 1962; 180:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/18\">",
"      Gall JC, Brewer GJ, Dern RJ. Studies of Glucose-6-Phosphate Dehydrogenase Activity of Individual Erythrocytes: The Methemoglobin-Elution Test for Identification of Females Heterozygous for G6PD Deficiency. Am J Hum Genet 1965; 17:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/19\">",
"      Rosen PJ, Johnson C, McGehee WG, Beutler E. Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency. Ann Intern Med 1971; 75:83.",
"     </a>",
"    </li>",
"    <li>",
"     file://g6pd.org/favism/english/index.mvc (Accessed on December 20, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/21\">",
"      Brewer GJ, Zarafonetis CJ. The haemolytic effect of various regimens of primaquine with chloroquine in American Negroes with G6PD deficiency and the lack of an effect of various antimalarial suppressive agents on erythrocyte metabolism. Bull World Health Organ 1967; 36:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/22\">",
"      Balinsky D, Gomperts E, Cayanis E, et al. Glucose-6-phosphate dehydrogenase Johannesburg: a new variant with reduced activity in a patient with congenital non-spherocytic haemolytic anaemia. Br J Haematol 1973; 25:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/23\">",
"      Corash L, Spielberg S, Bartsocas C, et al. Reduced chronic hemolysis during high-dose vitamin E administration in Mediterranean-type glucose-6-phosphate dehydrogenase deficiency. N Engl J Med 1980; 303:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/24\">",
"      Hafez M, Amar ES, Zedan M, et al. Improved erythrocyte survival with combined vitamin E and selenium therapy in children with glucose-6-phosphate dehydrogenase deficiency and mild chronic hemolysis. J Pediatr 1986; 108:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/25\">",
"      Benbassat J, Ben-Ishay D. Hereditary hemolytic anemia associated with glucose-6-phosphate dehydrogenase deficiency (Mediterranean type). Isr J Med Sci 1969; 5:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/26\">",
"      Johnson GJ, Vatassery GT, Finkel B, Allen DW. High-dose vitamin E does not decrease the rate of chronic hemolysis in glucose-6-phosphate dehydrogenase deficiency. N Engl J Med 1983; 308:1014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/27\">",
"      Newman JG, Newman TB, Bowie LJ, Mendelsohn J. An examination of the role of vitamin E in glucose-6-phosphate dehydrogenase deficiency. Clin Biochem 1979; 12:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/28\">",
"      Rovira A, De Angioletti M, Camacho-Vanegas O, et al. Stable in vivo expression of glucose-6-phosphate dehydrogenase (G6PD) and rescue of G6PD deficiency in stem cells by gene transfer. Blood 2000; 96:4111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/29\">",
"      Meloni T, Costa S, Dore A, Cutillo S. Phototherapy for neonatal hyperbilirubinemia in mature newborn infants with erythrocyte G-6-PD deficiency. J Pediatr 1974; 85:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/30\">",
"      Kaplan M, Abramov A. Neonatal hyperbilirubinemia associated with glucose-6-phosphate dehydrogenase deficiency in Sephardic-Jewish neonates: incidence, severity, and the effect of phototherapy. Pediatrics 1992; 90:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/31\">",
"      Itoh S, Onishi S. Kinetic study of the photochemical changes of (ZZ)-bilirubin IX alpha bound to human serum albumin. Demonstration of (EZ)-bilirubin IX alpha as an intermediate in photochemical changes from (ZZ)-bilirubin IX alpha to (EZ)-cyclobilirubin IX alpha. Biochem J 1985; 226:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/32\">",
"      Beutler E. G6PD deficiency. Blood 1994; 84:3613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/33\">",
"      Meloni T, Cagnazzo G, Dore A, Cutillo S. Phenobarbital for prevention of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborn infants. J Pediatr 1973; 82:1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/34\">",
"      Murki S, Dutta S, Narang A, et al. A randomized, triple-blind, placebo-controlled trial of prophylactic oral phenobarbital to reduce the need for phototherapy in G6PD-deficient neonates. J Perinatol 2005; 25:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/35\">",
"      Kaplan M, Vreman HJ, Hammerman C, et al. Contribution of haemolysis to jaundice in Sephardic Jewish glucose-6-phosphate dehydrogenase deficient neonates. Br J Haematol 1996; 93:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/36\">",
"      Seidman DS, Shiloh M, Stevenson DK, et al. Role of hemolysis in neonatal jaundice associated with glucose-6 phosphate dehydrogenase deficiency. J Pediatr 1995; 127:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/37\">",
"      Kaplan M, Rubaltelli FF, Hammerman C, et al. Conjugated bilirubin in neonates with glucose-6-phosphate dehydrogenase deficiency. J Pediatr 1996; 128:695.",
"     </a>",
"    </li>",
"    <li>",
"     Beutler E. Red blood cell enzyme disorders. In: Hematologic Disorders in Maternal-Fetal Medicine, Bern M, Frigoletto F Jr (Eds), Wiley-Liss, New York 1990. p.199.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/39\">",
"      Oppenheim A, Jury CL, Rund D, et al. G6PD Mediterranean accounts for the high prevalence of G6PD deficiency in Kurdish Jews. Hum Genet 1993; 91:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/40\">",
"      McCurdy PR, Morse EE. Glucose-6-phosphate dehydrogenase deficiency and blood transfusion. Vox Sang 1975; 28:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/41\">",
"      Shalev O, Manny N, Sharon R. Posttransfusional hemolysis in recipients of glucose-6-phosphate dehydrogenase-deficient erythrocytes. Vox Sang 1993; 64:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/42\">",
"      Mimouni F, Shohat S, Reisner SH. G6PD-deficient donor blood as a cause of hemolysis in two preterm infants. Isr J Med Sci 1986; 22:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39719/abstract/43\">",
"      Kumar P, Sarkar S, Narang A. Acute intravascular haemolysis following exchange transfusion with G-6-PD deficient blood. Eur J Pediatr 1994; 153:98.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7110 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-1745D172DA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_50_39719=[""].join("\n");
var outline_f38_50_39719=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21132140\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10276749\">",
"      EXPRESSION IN MALES AND FEMALES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Considering the diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Clinical and laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Methodology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      False negative results",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      TREATMENT AND PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Neonatal jaundice",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Screening for G6PD deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      ADDITIONAL INFORMATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21132140\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21132148\">",
"      When to suspect G6PD deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21132167\">",
"      How to diagnose G6PD deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21132229\">",
"      Treatment of hemolytic episodes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21132250\">",
"      Prevention of future hemolytic episodes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/7110\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7110|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?18/40/19085\" title=\"figure 1\">",
"      Physiology of G6PD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7110|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?25/28/26054\" title=\"picture 1\">",
"      Heinz body hemolytic anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7110|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?19/22/19821\" title=\"table 1\">",
"      Drugs and G6PD deficiency",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/3/18489?source=related_link\">",
"      Approach to the diagnosis of hemolytic anemia in the adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/18/27943?source=related_link\">",
"      Bilirubin metabolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/33/8729?source=related_link\">",
"      Clinical features, diagnosis, and treatment of methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/25/4505?source=related_link\">",
"      Clinical manifestations of glucose-6-phosphate dehydrogenase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/62/13289?source=related_link\">",
"      Genetics and pathophysiology of glucose-6-phosphate dehydrogenase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/44/43717?source=related_link\">",
"      Glossary of genetic terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/3/39992?source=related_link\">",
"      Pathogenesis and etiology of unconjugated hyperbilirubinemia in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?12/41/12946?source=related_link\">",
"      Patient information: Glucose-6-phosphate dehydrogenase deficiency (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/59/21434?source=related_link\">",
"      Treatment of unconjugated hyperbilirubinemia in term and late preterm infants",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_50_39720="Classification of acute myeloid leukemia";
var content_f38_50_39720=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Classification of acute myeloid leukemia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/50/39720/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/50/39720/contributors\">",
"     Charles A Schiffer, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/50/39720/contributors\">",
"     John Anastasi, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/50/39720/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/50/39720/contributors\">",
"     Richard A Larson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/50/39720/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/50/39720/contributors\">",
"     Rebecca F Connor, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/50/39720/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 29, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H26564673\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute myeloid leukemia (AML, also known as acute myelogenous leukemia and, less commonly, as acute non-lymphocytic leukemia) consists of a group of relatively well-defined hematopoietic neoplasms involving precursor cells committed to the myeloid line of cellular development (ie, those giving rise to granulocytic, monocytic, erythroid, or megakaryocytic elements).",
"   </p>",
"   <p>",
"    AML is characterized by a clonal proliferation of myeloid precursors with a reduced capacity to differentiate into more mature cellular elements. As a result, there is an accumulation of leukemic blasts or immature forms in the bone marrow, peripheral blood, and occasionally in other tissues, with a variable reduction in the production of normal red blood cells, platelets, and mature granulocytes. The increased production of malignant cells, along with a reduction in these mature elements, results in a variety of systemic consequences including anemia, bleeding, and an increased risk of infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/58/20393?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of acute myeloid leukemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/33/35354?source=see_link\">",
"     \"Pathogenesis of acute myeloid leukemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Following diagnosis, AML is classified using the World Health Organization (WHO) classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/1\">",
"     1",
"    </a>",
"    ]. The classification attempts to identify biologic entities in the hopes that future work will elucidate molecular pathways that might be amenable to targeted therapies.",
"   </p>",
"   <p>",
"    There are four main groups of AML recognized in this classification system [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      AML with recurrent genetic abnormalities &mdash; 11 percent",
"     </li>",
"     <li>",
"      AML with myelodysplasia-related features &mdash; 6 percent",
"     </li>",
"     <li>",
"      Therapy-related AML and MDS &mdash; 2 percent",
"     </li>",
"     <li>",
"      AML, not otherwise specified &mdash; 81 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The classification of AML using the WHO classification system will be presented here. The presenting signs and symptoms and diagnosis of AML are discussed separately as are the prognosis, cytogenetics, treatment, and complications of AML. Issues related to one of the AML variants, acute promyelocytic leukemia (AML-M3), are also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/58/20393?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of acute myeloid leukemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/55/36730?source=see_link\">",
"     \"Prognosis of acute myeloid leukemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/42/39594?source=see_link\">",
"     \"Cytogenetics in acute myeloid leukemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/41/30362?source=see_link\">",
"     \"Induction therapy for acute myeloid leukemia in younger adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/29/29146?source=see_link\">",
"     \"Treatment of acute myeloid leukemia in older adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/53/14168?source=see_link\">",
"     \"Overview of the complications of acute myeloid leukemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/12/200?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of acute promyelocytic leukemia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26565145\">",
"    <span class=\"h1\">",
"     AML WITH RECURRENT GENETIC ABNORMALITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The WHO category &ldquo;AML with recurrent genetic abnormalities&rdquo; accounts for approximately 11 percent of AML cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. It contains AML variants that contain genetic abnormalities of prognostic significance. There are seven defined structural abnormalities that define specific AML subtypes. In addition, there are two provisional entities identified at the molecular level (mutated NPM1 and mutated CEBPA).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26566224\">",
"    <span class=\"h2\">",
"     Defined structural abnormalities",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26566090\">",
"    <span class=\"h3\">",
"     AML with t(8;21)(q22;q22); RUNX1-RUNX1T1",
"    </span>",
"    &nbsp;&mdash;&nbsp;The balanced translocation t(8;21)(q22;q22), RUNX1-RUNX1T1 (previously AML1-ETO), is seen in approximately 7 percent of adults with newly diagnosed AML (",
"    <a class=\"graphic graphic_figure graphicRef53821 \" href=\"mobipreview.htm?2/1/2073\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/3\">",
"     3",
"    </a>",
"    ]; it is also the most frequent abnormality in children with AML [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/4\">",
"     4",
"    </a>",
"    ]. It is one of the three cytogenetic abnormalities in AML which, if found, result in the diagnosis of AML regardless of the bone marrow blast count [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The t(8;21) identifies a morphologically and clinically distinct subset with the following features [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The myeloblasts tend to have indented nuclei.",
"     </li>",
"     <li>",
"      The cytoplasm is generally basophilic with a prominent paranuclear hof that may contain a few azurophilic granules.",
"     </li>",
"     <li>",
"      Promyelocytes, myelocytes, and metamyelocytes are often prominent and may be large; their cytoplasm has a waxy, orange appearance and lacks a granular texture in Romanowsky-stained specimens.",
"     </li>",
"     <li>",
"      Auer rods are easily identified, and several may be present in a single cell.",
"     </li>",
"     <li>",
"      Bone marrow eosinophilia is common.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other morphologic features that suggest this diagnosis include blasts with long thin Auer rods, and maturation of the blasts to abnormal mature granulocytic elements with salmon colored cytoplasm with blue rims, and cytoplasmic globules, or Chediak-Higashi-like granules. This leukemia frequently has myeloid markers, but can also express CD19 and CD56. The malignant cells in some of these patients appear cytogenetically normal or contain only a detectable -Y or del(9q) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/8\">",
"     8",
"    </a>",
"    ]. However, fluorescence in situ hybridization (FISH) or reverse transcription polymerase chain reaction (RT-PCR) methods will demonstrate the cryptic RUNX1-RUNX1T1 rearrangement.",
"   </p>",
"   <p>",
"    The leukemia is associated with a more favorable prognosis. The presence of c-KIT mutations is an adverse prognostic features in patients with t(8;21). Surprisingly, patients can have transcripts of the RUNX1-RUNX1T1 detected by RT-PCR even when they have been in remission for many years. Further details regarding this translocation are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/42/39594?source=see_link&amp;anchor=H7#H7\">",
"     \"Cytogenetics in acute myeloid leukemia\", section on '8;21 translocation in AML'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26566098\">",
"    <span class=\"h3\">",
"     AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities of chromosome 16 are seen in approximately 7 percent of adults with newly diagnosed AML (",
"    <a class=\"graphic graphic_figure graphicRef53821 \" href=\"mobipreview.htm?2/1/2073\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/3\">",
"     3",
"    </a>",
"    ]. One of these abnormalities, AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22), was previously classified under acute myelomonocytic leukemia (AMML, FAB M4Eo). This leukemia occurs in younger patients and can present as an extramedullary myeloid sarcoma. &nbsp;",
"   </p>",
"   <p>",
"    Morphologically, this leukemia has myeloblasts, a significant monocytic component that may be non-specific esterase reaction-negative, and variable numbers of abnormal immature eosinophils that have atypical purple-violet granules in addition to eosinophilic granules in the cytoplasm (",
"    <a class=\"graphic graphic_picture graphicRef58646 \" href=\"mobipreview.htm?17/14/17633\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef71045 \" href=\"mobipreview.htm?18/62/19424\">",
"     picture 2",
"    </a>",
"    ). In typical cases, the bone marrow demonstrates abnormalities of the eosinophils in addition to the typical morphologic features of AML. In particular, the eosinophils are seen at all stages of maturation with no significant signs of maturation arrest, but with immature eosinophilic granules seen in the promyelocyte and myelocyte stages of development [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/5\">",
"     5",
"    </a>",
"    ]. These immature granules are typically larger than normal and purple-violet in color. They may be so prominent that they obscure the cell morphology. While these morphologic changes are typical for this disorder, some patients with the",
"    <span class=\"nowrap\">",
"     CBFB/MYH11",
"    </span>",
"    fusion gene do not have these abnormalities in most of their bone marrow eosinophils [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This leukemia is associated with a more favorable prognosis although cases with an additional c-KIT mutation may do more poorly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/10\">",
"     10",
"    </a>",
"    ]. Further details regarding this translocation are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/42/39594?source=see_link&amp;anchor=H993131070#H993131070\">",
"     \"Cytogenetics in acute myeloid leukemia\", section on 'Inv(16) and t(16;16)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26566189\">",
"    <span class=\"h3\">",
"     APL with t(15;17)(q24.1;q21.1); PML-RARA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute promyelocytic leukemia (APL, previously called AML-M3) is characterized by the balanced translocation t(15;17)(q24.1;q21.1) (",
"    <a class=\"graphic graphic_figure graphicRef53821 \" href=\"mobipreview.htm?2/1/2073\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. This rearrangement is seen in 13 percent of newly diagnosed AML and is highly specific for APL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    APL is a unique clinicopathological entity characterized by the infiltration of the bone marrow by promyelocytes in association with clinical or laboratory evidence of disseminated intravascular coagulation (DIC) and fibrinolysis, which may worsen during the initial cytolytic response to chemotherapy. A characteristic folded, reniform (kidney-shaped), or bilobed nucleus is invariably found in some of the promyelocytes; coarse azurophilic granules and multiple Auer rods are also common (",
"    <a class=\"graphic graphic_picture graphicRef82863 \" href=\"mobipreview.htm?2/11/2224\">",
"     picture 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/7,11\">",
"     7,11",
"    </a>",
"    ]. The microgranular variant of APL differs from the more frequent hypergranular type in that the cytoplasmic granules in the leukemia cells are smaller and sometimes beneath the limit of resolution of the light microscope [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/7,11\">",
"     7,11",
"    </a>",
"    ]. The diagnosis of APL is presented in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/12/200?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of acute promyelocytic leukemia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    APL represents a medical emergency with a high rate of early mortality, but, if managed appropriately, usually has a favorable outcome. Further details regarding this translocation and the management of APL are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/42/39594?source=see_link&amp;anchor=H8#H8\">",
"     \"Cytogenetics in acute myeloid leukemia\", section on '15;17 translocation in APL'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/11/28858?source=see_link\">",
"     \"Initial treatment of acute promyelocytic leukemia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26566196\">",
"    <span class=\"h3\">",
"     AML with t(9;11)(p22;q23); MLLT3-MLL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rearrangements of 11q are seen in approximately 6 percent of young adults with newly diagnosed AML and up to 12 percent of children with AML [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/3,5\">",
"     3,5",
"    </a>",
"    ]. The t(9;11) translocation can present with disseminated intravascular coagulation (DIC), and high white cell counts with gingival or skin infiltration. Morphologically, monoblasts and promonocytes usually predominate and show strong positive non-specific esterase reactions. The monoblasts often lack myeloperoxidase reactivity. AML with t(6;9)(p23;q34), DEK-NUP214 has an intermediate prognosis. Further details regarding translocations involving MLL are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/42/39594?source=see_link&amp;anchor=H993131111#H993131111\">",
"     \"Cytogenetics in acute myeloid leukemia\", section on 'Rearrangements of 11q23'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26566203\">",
"    <span class=\"h3\">",
"     AML with t(6;9)(p23;q34); DEK-NUP214",
"    </span>",
"    &nbsp;&mdash;&nbsp;AML with t(6;9)(p23;q34), DEK-NUP214, is seen in approximately 1 percent of adults and approximately 10 percent of children with newly diagnosed AML [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/3,13\">",
"     3,13",
"    </a>",
"    ]. This subtype of AML typically presents with variable morphology, basophilia, pancytopenia, and single or multilineage dysplasia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/5,14\">",
"     5,14",
"    </a>",
"    ]. The tumor cells typically express CD13, CD33, CD38, CD45, and HLA-DR. There is a high incidence of FLT3 internal tandem duplications. AML with t(6;9)(p23;q34); DEK-NUP214 has a poor prognosis. Further details regarding this translocation are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/42/39594?source=see_link&amp;anchor=H983671238#H983671238\">",
"     \"Cytogenetics in acute myeloid leukemia\", section on 't(6;9)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26566210\">",
"    <span class=\"h3\">",
"     AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1",
"    </span>",
"    &nbsp;&mdash;&nbsp;The t(3;3) and inv(3) account for approximately 1 percent of AML cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/3\">",
"     3",
"    </a>",
"    ]. This abnormality is seen in de novo AML and in therapy-related",
"    <span class=\"nowrap\">",
"     MDS/AML.",
"    </span>",
"    Patients are anemic but may have normal or elevated platelet counts. It is frequently associated with dysplasia, which is quite prominent in the megakaryocytic lineage. Cytogenetic abnormalities of 3q are associated with increased atypical megakaryocytes in the bone marrow [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. These cytogenetic abnormalities are associated with aggressive disease and a short survival time. Further details regarding this translocation are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/42/39594?source=see_link&amp;anchor=H11#H11\">",
"     \"Cytogenetics in acute myeloid leukemia\", section on 't(3;3) and inv(3) in AML with thrombocytosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26566217\">",
"    <span class=\"h3\">",
"     AML (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1",
"    </span>",
"    &nbsp;&mdash;&nbsp;AML with the t(1;22)(p13;q13), RBM15-MKL1, is a rare entity accounting for &lt;0.5 percent of cases of newly diagnosed AML [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/3,5\">",
"     3,5",
"    </a>",
"    ]. It is typically a megakaryoblastic process occurring in infants, although it is not seen in patients with Down syndrome. Most patients present with marked hepatosplenomegaly, anemia, thrombocytopenia, and a moderately elevated white cell count [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/18\">",
"     18",
"    </a>",
"    ]. Sometimes it can present as a mass and mimic sarcoma. Morphologically, the cells resemble those of acute megakaryoblastic leukemia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/42/39594?source=see_link&amp;anchor=H983671253#H983671253\">",
"     \"Cytogenetics in acute myeloid leukemia\", section on 't(1;22)'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H26566370\">",
"     'Acute megakaryoblastic leukemia'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26566297\">",
"    <span class=\"h2\">",
"     AML with gene mutations",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26566304\">",
"    <span class=\"h3\">",
"     AML with mutated NPM1",
"    </span>",
"    &nbsp;&mdash;&nbsp;AML with mutations of the nucleophosmin gene (NPM1) are considered as a provisional entity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/18\">",
"     18",
"    </a>",
"    ]. The mutation is seen in approximately one-third of all cases of AML and does not constitute a unique group. The presence of the NPM1 mutation confers a better prognosis, although when seen in conjunction with mutations in FLT3, the prognosis is inferior. Patients with NPM1 mutations and evidence of multilineage dysplasia (MLD) appear to have a similar outcome to those with NPM1 mutations and no MLD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/19\">",
"     19",
"    </a>",
"    ]. This is discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/55/36730?source=see_link&amp;anchor=H12#H12\">",
"     \"Prognosis of acute myeloid leukemia\", section on 'Nucleophosmin gene'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26566311\">",
"    <span class=\"h3\">",
"     AML with mutated CEBPA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutation in the CEBPA",
"    <span class=\"nowrap\">",
"     (CCAAT/enhancer",
"    </span>",
"    binding protein alpha) gene are seen in approximately 6 to 15 percent of AML, commonly in cases with a normal karyotype. Cases with this mutation are associated with a better prognosis, although when seen in conjunction with mutations in FLT3, the prognosis is inferior. This is discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/55/36730?source=see_link&amp;anchor=H14#H14\">",
"     \"Prognosis of acute myeloid leukemia\", section on 'CEBPA gene'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/55/36730?source=see_link&amp;anchor=H10#H10\">",
"     \"Prognosis of acute myeloid leukemia\", section on 'FLT3 gene'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26565152\">",
"    <span class=\"h1\">",
"     AML WITH MDS-RELATED FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;AML with myelodysplasia-related features (previously called AML with multilineage dysplasia) is defined by cases that fit the criteria for a diagnosis of AML (&ge;20 percent blasts), without a history of prior cytotoxic therapy for an unrelated disease, with one or more of the following three characteristics associated with myelodysplasia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/18,20\">",
"     18,20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/57/41882?source=see_link\">",
"     \"Clinical manifestations and diagnosis of the myelodysplastic syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      AML that evolves from previously documented myelodysplastic syndrome (MDS).",
"     </li>",
"     <li>",
"      AML that demonstrates MDS-related cytogenetic abnormalities, such as monosomy 5 or del(5q), monosomy 7 or del(7q), isochromosome 17p.",
"     </li>",
"     <li>",
"      AML with morphologically identified multilineage dysplasia, defined as dysplasia present in &ge;50 percent of cells in two or more hematopoietic lineages.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following are examples of dysplastic changes that may be seen in AML with MDS-related features:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dysplastic neutrophils that have hypogranular cytoplasm, hyposegmented nuclei (eg, pseudo-Pelger-Huet cells),",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      bizarrely segmented nuclei.",
"     </li>",
"     <li>",
"      Dysplastic erythrocytes that demonstrate megaloblastoid change, karyorrhexis, nuclear irregularity, nuclear fragmentation, multinucleation, ring sideroblasts, cytoplasmic vacuoles,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      periodic acid-Schiff positivity.",
"     </li>",
"     <li>",
"      Dysplastic megakaryocytes that are small (ie, micro-megakaryocytes) or are of normal to large size with non-lobulated or multiple small widely separated nuclei.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with AML who have a prior history of MDS or have MDS-related cytogenetic abnormalities have a poor outcome with conventional therapy. Such patients frequently demonstrate multilineage dysplasia (MLD). In contrast, the identification of MLD in the absence of these two features may not predict a poor outcome.",
"   </p>",
"   <p>",
"    A retrospective analysis of 408 patients with AML with MDS-related features or AML, not otherwise specified (AML,NOS) examined the prognostic implication of these three diagnostic features [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/21\">",
"     21",
"    </a>",
"    ]. Patients whose AML was categorized by the WHO classification as AML with MDS-related features based solely upon the presence of MLD had a similar median event-free survival (17 versus 16 months) and similar rates of three-year overall survival (57 versus 55 percent) as patients with AML,NOS. In comparison, MDS-related cytogenetics predicted an inferior outcome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26565159\">",
"    <span class=\"h1\">",
"     THERAPY-RELATED AML",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of therapy-related myeloid neoplasm (t-MN) is made when evaluation of the peripheral blood and bone marrow demonstrates morphologic, immunophenotypic, and cytogenetic changes consistent with the diagnosis of AML, MDS, or",
"    <span class=\"nowrap\">",
"     MDS/MPN",
"    </span>",
"    in a patient with prior exposure to cytotoxic agents. Details on the diagnosis and treatment of t-MN, including t-AML, are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/35/39480?source=see_link\">",
"     \"Therapy-related myeloid neoplasms: Acute myeloid leukemia and myelodysplastic syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26565166\">",
"    <span class=\"h1\">",
"     AML NOT OTHERWISE SPECIFIED",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cases of AML that do not meet the criteria for the categories described above are classified as AML, not otherwise specified (NOS). These cases are further subclassified by morphology that is similar to that used in the previous French, American, and British (FAB) classification system (",
"    <a class=\"graphic graphic_table graphicRef63050 \" href=\"mobipreview.htm?15/48/16141\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef71030 \" href=\"mobipreview.htm?36/38/37484\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/6,18\">",
"     6,18",
"    </a>",
"    ]:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26566318\">",
"    <span class=\"h2\">",
"     AML with minimal differentiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;AML with minimal differentiation (equivalent to FAB M0) accounts for &lt;5 percent of AML. In this leukemia, the blast cells are usually medium sized with a round or minimally indented nucleus, dispersed nuclear chromatin, and one or two nucleoli (",
"    <a class=\"graphic graphic_picture graphicRef80658 \" href=\"mobipreview.htm?41/61/42961\">",
"     picture 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. There are no cytoplasmic granules or Auer rods and they cannot be differentiated from acute lymphocytic leukemia based upon morphology alone. Although the blasts are negative for the myeloperoxidase (MPO) or Sudan black B (SBB) reactions, myeloid lineage is defined by the presence of myeloid associated markers. Most cases express antigens of early hematopoiesis (eg, CD34, CD38, HLA-DR) and the myeloid antigens CD13, CD117, and CD33. They lack antigens of more mature myeloid differentiation such as CD14, CD15, CD11b, and CD64, and can express the T cell marker CD7.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26566325\">",
"    <span class=\"h2\">",
"     AML without maturation",
"    </span>",
"    &nbsp;&mdash;&nbsp;AML without maturation (equivalent to FAB M1) accounts for 5 to 10 percent of AML. This type of AML is characterized by a high percentage of blasts (&gt;90 percent of total cells) and fewer than 10 percent of cells showing differentiation past the blast stage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/18\">",
"     18",
"    </a>",
"    ]. The blasts in this leukemia are large cells with a high nuclear:cytoplasmic ratio with grayish blue cytoplasm and a nucleus containing one to two distinct nucleoli (",
"    <a class=\"graphic graphic_picture graphicRef59646 \" href=\"mobipreview.htm?23/51/24368\">",
"     picture 5",
"    </a>",
"    ). Unlike AML with minimal differentiation, at least 3 percent of the blasts stain for MPO",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    SBB, and some cases may demonstrate azurophilic granules",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    Auer rods. Many cases express antigens of early hematopoiesis (eg, CD34, CD38, HLA-DR), but also express one or more myeloid-associated antigens (eg, CD13, CD33, CD117). Markers of granulocytic maturation (eg, CD15, CD65) are not expressed in most cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26566332\">",
"    <span class=\"h2\">",
"     AML with maturation",
"    </span>",
"    &nbsp;&mdash;&nbsp;AML with maturation (equivalent to FAB M2) accounts for 10 percent of AML. The bone marrow contains blasts with and without azurophilic granules (",
"    <a class=\"graphic graphic_picture graphicRef68390 \" href=\"mobipreview.htm?30/6/30816\">",
"     picture 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/18\">",
"     18",
"    </a>",
"    ]. Auer rods are common. At least 10 percent of the bone marrow cells show differentiation past the blast stage to promyelocytes, myelocytes,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mature neutrophils. It is assumed that the maturing cells are part of the leukemic clone although this is difficult to prove. Eosinophil precursors, basophils, and mast cells may be increased. A fraction of blasts may express antigens of early hematopoiesis (eg, CD34, CD38, HLA-DR), but the majority of cells express myeloid-associated antigens (eg, CD13, CD33, CD65, CD11b, and CD15). Monocytic markers (eg, CD14, CD64) are usually negative.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26566339\">",
"    <span class=\"h2\">",
"     Acute myelomonocytic leukemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute myelomonocytic leukemia (equivalent to FAB M4) accounts for 5 to 10 percent of AML. This leukemia has at least 20 percent blasts (either myeloblasts, monoblasts,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    promonocytes) in the bone marrow or blood. In addition to myeloblasts, there is a significant monocytic component, with monocytes and monocytic precursors accounting for at least 20 percent of the marrow cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/18\">",
"     18",
"    </a>",
"    ]. The monocytes can be recognized morphologically or with the help of non-specific esterase reactions, or by immunophenotyping (with expression of CD14, CD11c, CD64 and lysozyme).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26566346\">",
"    <span class=\"h2\">",
"     Acute monoblastic and monocytic leukemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute monoblastic and monocytic leukemia (equivalent to FAB M5A and B) accounts for &lt;5 percent of cases of AML each. The marrow is composed of an admixture of monoblasts, promonocytes, and monocytes with a minor percentage of neutrophils (",
"    <a class=\"graphic graphic_picture graphicRef58646 \" href=\"mobipreview.htm?17/14/17633\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/18\">",
"     18",
"    </a>",
"    ]. Promonocytes are considered blast equivalents for determining the blast percentage. Auer rods are rare and hemophagocytosis may be present.",
"    <br/>",
"    <br/>",
"    Almost all cases express the HLA-DR antigen of early hematopoiesis. Myeloid antigens are variably expressed and there is usually expression of at least two markers of monocytic differentiation (eg, CD14, CD4, CD11b, CD11c, CD64, CD68, CD36, and lysozyme). The terms monoblastic and monocytic leukemia are used depending upon the predominant component:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In acute monoblastic leukemia, the vast majority of the cells (&gt;80 percent) are monoblasts. Monoblasts are large with abundant moderately to intensely basophilic cytoplasm, which may demonstrate pseudopod formation, scattered fine azurophilic granules, and vacuoles. Nuclei are round with delicate lacy chromatin and one or more large prominent nucleoli (",
"      <a class=\"graphic graphic_picture graphicRef51084 \" href=\"mobipreview.htm?27/39/28273\">",
"       picture 7",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      In acute monocytic leukemia, promonocytes and mature monocytes predominate with less than 80 percent monoblasts. Promonocytes are large with less basophilic and sometimes more obviously granulated cytoplasm with occasional large azurophilic granules and vacuoles. The nucleus is irregular with a delicately convoluted configuration (",
"      <a class=\"graphic graphic_picture graphicRef63816 \" href=\"mobipreview.htm?33/43/34481\">",
"       picture 8",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef76635 \" href=\"mobipreview.htm?24/27/25010\">",
"       picture 9",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26566353\">",
"    <span class=\"h2\">",
"     Acute erythroid leukemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute erythroid leukemia (equivalent to FAB M6, erythroleukemia, or Di Guglielmo&rsquo;s disease) accounts for &lt;5 percent of AML. The erythroblasts do not express markers of myeloid lineage and do not stain with MPO [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/18\">",
"     18",
"    </a>",
"    ]. They may express CD117 and do react with antibodies to hemoglobin A and glycophorin. It is notable that cases with prominent dysplasia might better be classified into the AML with myelodysplastic-related features category [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/26\">",
"     26",
"    </a>",
"    ]. They typically have myelodysplastic associated cytogenetic changes as well. Two types of this leukemia are recognized, the",
"    <span class=\"nowrap\">",
"     erythroid/myeloid",
"    </span>",
"    type and the \"pure\" type.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the",
"      <span class=\"nowrap\">",
"       erythroid/myeloid",
"      </span>",
"      type, erythroid precursors account for more than 50 percent of the nucleated marrow elements and myeloblasts account for more than 20 percent of the non erythroid forms. The bone marrow is composed of erythroid precursors of all stages of maturation, often with a shift towards immaturity. Dysplastic changes are present with features of nuclear atypia, gigantism, and multinucleation, admixed with myeloblasts and dysplasia also in the granulocytic and megakaryocytic lineages (",
"      <a class=\"graphic graphic_picture graphicRef52638 \" href=\"mobipreview.htm?32/5/32849\">",
"       picture 10",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      In the \"pure\" form, erythroblasts, primarily at the pronormoblast stage predominate and account for &gt;80 percent of the marrow cells. Sometimes they have vacuolization in the cytoplasm surrounding the nucleus. This has been referred to as a &ldquo;pearl necklace&rdquo;, and should not be confused with the vacuolated cells seen in Burkitt",
"      <span class=\"nowrap\">",
"       leukemia/lymphoma.",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26566370\">",
"    <span class=\"h2\">",
"     Acute megakaryoblastic leukemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute megakaryoblastic leukemia (equivalent to FAB M7) accounts for &lt;5 percent of AML. The bone marrow is comprised of at least 20 percent blasts of which at least half are of megakaryocyte lineage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/27-29\">",
"     27-29",
"    </a>",
"    ]. Bone marrow fibrosis and a leukoerythroblastic blood picture without splenomegaly (previously called \"acute myelofibrosis\") may be present. Megakaryoblasts are differentiated from other blasts by virtue of either maturation to cells resembling normal megakaryocytes, or by special staining for the megakaryocytic markers CD41 or CD61 or for the products of megakaryocytes, such as von Willebrand factor or platelet type glycoproteins. Megakaryoblasts are medium to large cells with basophilic, often agranular cytoplasm that may have distinct cytoplasmic blebs or pseudopod formation. The nucleus is round, slightly irregular or indented with fine reticular chromatin and one to three nucleoli (",
"    <a class=\"graphic graphic_picture graphicRef65416 \" href=\"mobipreview.htm?38/9/39058\">",
"     picture 11",
"    </a>",
"    ). The megakaryoblasts are consistently negative for MPO, SBB, and naphthyl-ASD-chloroacetate esterase. Megakaryoblasts are not equivalent to micro-megakaryocytes, which are dysplastic but mature megakaryocytes.",
"    <br/>",
"    <br/>",
"    Acute megakaryoblastic leukemia in infants and children may be associated with the presence of t(1;22) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/30\">",
"     30",
"    </a>",
"    ] and Down syndrome (trisomy 21) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/31\">",
"     31",
"    </a>",
"    ], and in adults with a high incidence of an antecedent hematologic disorder, myelodysplastic syndrome,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    prior chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/15/26874?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical features and diagnosis of Down syndrome\", section on 'Acute megakaryoblastic leukemia (AMKL)'",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"    Those with t(1;22) are classified into the group with recurring genetic abnormalities, and those associated with Down syndrome are classified separately. Like erythroleukemia, many cases of acute megakaryoblastic leukemia in adults have prominent multilineage dysplasia and might better be classified into the AML with myelodysplastic-related features category. They also typically have myelodysplastic associated cytogenetic changes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26566380\">",
"    <span class=\"h2\">",
"     Acute basophilic leukemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute basophilic leukemia accounts for &lt;1 percent of AML. Blasts are of medium size with moderately basophilic cytoplasm containing a variable number of coarse basophilic granules that have metachromatic positivity with toluidine blue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/18\">",
"     18",
"    </a>",
"    ]. The nucleus is oval, round, or bilobed with dispersed chromatin and one to three prominent nucleoli and a high nuclear to cytoplasmic ratio. Dysplastic features may be present. Blast cells express myeloid markers (eg, CD13, CD33), CD123, CD203c, and CD11b, but do not express other monocytic markers. They are negative for CD117. Care should be taken not to mistake a case of acute basophilic leukemia for chronic myeloid leukemia (CML) or CML in blast crisis, as CML typically has increased basophils. If the t(6;9) is identified, the case is best classified in the group with recurrent cytogenetic abnormalities. (See",
"    <a class=\"local\" href=\"#H26565145\">",
"     'AML with recurrent genetic abnormalities'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26566387\">",
"    <span class=\"h2\">",
"     Acute panmyelosis with myelofibrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute panmyelosis with myelofibrosis is a rare subtype of AML. This entity is incorporated into the AML category because of its association with increased blasts and its highly aggressive nature. The bone marrow is hypercellular and diffusely fibrotic with increased erythroid, granulocytic, and megakaryocytic precursors (panmyelosis) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39720/abstract/18\">",
"     18",
"    </a>",
"    ]. Blasts are increased but difficult to quantify since often the marrow cannot be aspirated. The blasts may be of different myeloid lineages including myeloblasts, erythroblasts, and megakaryoblasts. Unlike chronic or primary myelofibrosis, and because of the abrupt nature of the disease, patients do not have splenomegaly, extramedullary hematopoiesis or signs of this in the blood (eg, teardrop red blood cells and a leukoerythroblastic picture).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26564681\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute myeloid leukemia (AML) consists of a group of relatively well-defined hematopoietic neoplasms involving precursor cells committed to the myeloid line of cellular development (ie, those giving rise to granulocytic, monocytic, erythroid, or megakaryocytic elements).",
"     </li>",
"     <li>",
"      Following diagnosis, AML is classified into four main groups using the World Health Organization classification system based upon a combination of morphology, immunophenotype, genetics, and clinical features. The classification attempts to identify biologic entities in the hopes that future work will elucidate molecular pathways that might be amenable to targeted therapies.",
"     </li>",
"     <li>",
"      AML with recurrent genetic abnormalities includes seven specific AML subtypes with defined structural abnormalities and two provisional entities identified at the molecular level (mutated NPM1 and mutated CEBPA). (See",
"      <a class=\"local\" href=\"#H26565145\">",
"       'AML with recurrent genetic abnormalities'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The t(8;21) identifies a morphologically and clinically distinct subset of AML characterized by myeloblasts with basophilic cytoplasm, indented nuclei, and prominent Auer rods. (See",
"      <a class=\"local\" href=\"#H26566090\">",
"       'AML with t(8;21)(q22;q22); RUNX1-RUNX1T1'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22) is characterized by myeloblasts with a significant monocytic component and abnormalities in the eosinophils. (See",
"      <a class=\"local\" href=\"#H26566098\">",
"       'AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The t(15;17) defines acute promyelocytic leukemia (APL), which is characterized by the infiltration of the bone marrow by promyelocytes, often with a folded, reniform (kidney-shaped), or bilobed nucleus in association with clinical or laboratory evidence of disseminated intravascular coagulation and fibrinolysis. (See",
"      <a class=\"local\" href=\"#H26566189\">",
"       'APL with t(15;17)(q24.1;q21.1); PML-RARA'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The t(9;11) translocation can present with a high white count, disseminated intravascular coagulation, and gingival or skin infiltration. Morphologically, monoblasts and promonocytes usually predominate. (See",
"      <a class=\"local\" href=\"#H26566196\">",
"       'AML with t(9;11)(p22;q23); MLLT3-MLL'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      AML with t(6;9)(p23;q34), DEK-NUP214 typically presents with basophilia, pancytopenia, and dysplasia with circulating monoblasts and promonocytes. (See",
"      <a class=\"local\" href=\"#H26566203\">",
"       'AML with t(6;9)(p23;q34); DEK-NUP214'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The t(3;3) and inv(3) is frequently associated with dysplasia, especially involving the megakaryocytic lineage. (See",
"      <a class=\"local\" href=\"#H26566210\">",
"       'AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      AML with the t(1;22)(p13;q13), RBM15-MKL1 is a rare entity typically diagnosed in infants who present with marked hepatosplenomegaly, anemia, thrombocytopenia, and a moderately elevated white cell count. (See",
"      <a class=\"local\" href=\"#H26566217\">",
"       'AML (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      AML with myelodysplasia-related features (previously called AML with multilineage dysplasia) includes cases that fit the criteria for a diagnosis of AML without a history of prior cytotoxic therapy that have evolved from previously documented myelodysplastic syndrome (MDS), contain MDS-related cytogenetic abnormalities,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      demonstrate multilineage dysplasia. (See",
"      <a class=\"local\" href=\"#H26565152\">",
"       'AML with MDS-related features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of therapy-related myeloid neoplasm (t-MN) is made when AML, MDS, or",
"      <span class=\"nowrap\">",
"       MDS/MPN",
"      </span>",
"      is diagnosed in a patient with prior exposure to cytotoxic agents. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/35/39480?source=see_link\">",
"       \"Therapy-related myeloid neoplasms: Acute myeloid leukemia and myelodysplastic syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The vast majority of cases of AML do not meet the criteria for the categories described above and are classified as AML, not otherwise specified (NOS). These cases are further subclassified by morphology that is similar to that used in the previous French, American, and British (FAB) classification system (",
"      <a class=\"graphic graphic_table graphicRef63050 \" href=\"mobipreview.htm?15/48/16141\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef71030 \" href=\"mobipreview.htm?36/38/37484\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H26565166\">",
"       'AML not otherwise specified'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/1\">",
"      Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/2\">",
"      Dores GM, Devesa SS, Curtis RE, et al. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood 2012; 119:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/3\">",
"      Grimwade D, Hills RK, Moorman AV, et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 2010; 116:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/4\">",
"      Nucifora G, Rowley JD. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 1995; 86:1.",
"     </a>",
"    </li>",
"    <li>",
"     Swerdlow SH, Campo E, Harris NL, et al. (Eds). World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press, Lyon 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/6\">",
"      Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/7\">",
"      Bitter MA, Le Beau MM, Rowley JD, et al. Associations between morphology, karyotype, and clinical features in myeloid leukemias. Hum Pathol 1987; 18:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/8\">",
"      Peniket A, Wainscoat J, Side L, et al. Del (9q) AML: clinical and cytological characteristics and prognostic implications. Br J Haematol 2005; 129:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/9\">",
"      Poirel H, Radford-Weiss I, Rack K, et al. Detection of the chromosome 16 CBF beta-MYH11 fusion transcript in myelomonocytic leukemias. Blood 1995; 85:1313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/10\">",
"      Schwind S, Edwards CG, Nicolet D, et al. inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations. Blood 2013; 121:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/11\">",
"      Larson RA, Kondo K, Vardiman JW, et al. Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am J Med 1984; 76:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/12\">",
"      Melnick A, Licht JD. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999; 93:3167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/13\">",
"      Forestier E, Heim S, Blennow E, et al. Cytogenetic abnormalities in childhood acute myeloid leukaemia: a Nordic series comprising all children enrolled in the NOPHO-93-AML trial between 1993 and 2001. Br J Haematol 2003; 121:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/14\">",
"      Chi Y, Lindgren V, Quigley S, Gaitonde S. Acute myelogenous leukemia with t(6;9)(p23;q34) and marrow basophilia: an overview. Arch Pathol Lab Med 2008; 132:1835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/15\">",
"      Pintado T, Ferro MT, San Rom&aacute;n C, et al. Clinical correlations of the 3q21;q26 cytogenetic anomaly. A leukemic or myelodysplastic syndrome with preserved or increased platelet production and lack of response to cytotoxic drug therapy. Cancer 1985; 55:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/16\">",
"      Bitter MA, Neilly ME, Le Beau MM, et al. Rearrangements of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia. Blood 1985; 66:1362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/17\">",
"      Chang VT, Aviv H, Howard LM, Padberg F. Acute myelogenous leukemia associated with extreme symptomatic thrombocytosis and chromosome 3q translocation: case report and review of literature. Am J Hematol 2003; 72:20.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, Swerdlow SH, Campo E, Harris NL (Eds), IARC Press, Lyon 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/19\">",
"      Falini B, Macijewski K, Weiss T, et al. Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1). Blood 2010; 115:3776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/20\">",
"      Weinberg OK, Seetharam M, Ren L, et al. Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system. Blood 2009; 113:1906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/21\">",
"      Miesner M, Haferlach C, Bacher U, et al. Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as \"AML not otherwise specified\" (AML-NOS) or \"AML with myelodysplasia-related changes\" (AML-MRC). Blood 2010; 116:2742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/22\">",
"      Lee EJ, Pollak A, Leavitt RD, et al. Minimally differentiated acute nonlymphocytic leukemia: a distinct entity. Blood 1987; 70:1400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/23\">",
"      B&eacute;n&eacute; MC, Bernier M, Casasnovas RO, et al. Acute myeloid leukaemia M0: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients. Br J Haematol 2001; 113:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/24\">",
"      Roumier C, Eclache V, Imbert M, et al. M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Fran&ccedil;ais d'H&eacute;matologie Cellulaire (GFHC) and the Groupe Fran&ccedil;ais de Cytog&eacute;n&eacute;tique H&eacute;matologique (GFCH). Blood 2003; 101:1277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/25\">",
"      Haferlach T, Schoch C, Schnittger S, et al. Distinct genetic patterns can be identified in acute monoblastic and acute monocytic leukaemia (FAB AML M5a and M5b): a study of 124 patients. Br J Haematol 2002; 118:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/26\">",
"      Hasserjian RP, Zuo Z, Garcia C, et al. Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification. Blood 2010; 115:1985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/27\">",
"      Tallman MS, Neuberg D, Bennett JM, et al. Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience. Blood 2000; 96:2405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/28\">",
"      Dastugue N, Lafage-Pochitaloff M, Pag&egrave;s MP, et al. Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Fran&ccedil;ais de Cytog&eacute;n&eacute;tique H&eacute;matologique (GFCH). Blood 2002; 100:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/29\">",
"      Oki Y, Kantarjian HM, Zhou X, et al. Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center. Blood 2006; 107:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/30\">",
"      Ma Z, Morris SW, Valentine V, et al. Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. Nat Genet 2001; 28:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39720/abstract/31\">",
"      Zipursky A. Transient leukaemia--a benign form of leukaemia in newborn infants with trisomy 21. Br J Haematol 2003; 120:930.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 86098 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-655B890CD5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_50_39720=[""].join("\n");
var outline_f38_50_39720=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26564681\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26564673\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26565145\">",
"      AML WITH RECURRENT GENETIC ABNORMALITIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26566224\">",
"      Defined structural abnormalities",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26566090\">",
"      - AML with t(8;21)(q22;q22); RUNX1-RUNX1T1",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26566098\">",
"      - AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26566189\">",
"      - APL with t(15;17)(q24.1;q21.1); PML-RARA",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26566196\">",
"      - AML with t(9;11)(p22;q23); MLLT3-MLL",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26566203\">",
"      - AML with t(6;9)(p23;q34); DEK-NUP214",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26566210\">",
"      - AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26566217\">",
"      - AML (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26566297\">",
"      AML with gene mutations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26566304\">",
"      - AML with mutated NPM1",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26566311\">",
"      - AML with mutated CEBPA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26565152\">",
"      AML WITH MDS-RELATED FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26565159\">",
"      THERAPY-RELATED AML",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26565166\">",
"      AML NOT OTHERWISE SPECIFIED",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26566318\">",
"      AML with minimal differentiation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26566325\">",
"      AML without maturation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26566332\">",
"      AML with maturation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26566339\">",
"      Acute myelomonocytic leukemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26566346\">",
"      Acute monoblastic and monocytic leukemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26566353\">",
"      Acute erythroid leukemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26566370\">",
"      Acute megakaryoblastic leukemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26566380\">",
"      Acute basophilic leukemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26566387\">",
"      Acute panmyelosis with myelofibrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26564681\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/86098\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/86098|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?2/1/2073\" title=\"figure 1\">",
"      Chromosomal abnormalities AML",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/86098|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?17/14/17633\" title=\"picture 1\">",
"      AML FAB M4",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?18/62/19424\" title=\"picture 2\">",
"      AML FAB M4EO",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?2/11/2224\" title=\"picture 3\">",
"      Typical hypergranular APL peripheral smear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?41/61/42961\" title=\"picture 4\">",
"      AML FAB M0",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?23/51/24368\" title=\"picture 5\">",
"      AML FAB M1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?30/6/30816\" title=\"picture 6\">",
"      AML FAB M2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?27/39/28273\" title=\"picture 7\">",
"      AML FAB M5",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?33/43/34481\" title=\"picture 8\">",
"      AML FAB M5B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?24/27/25010\" title=\"picture 9\">",
"      AML FAB M5B maturation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?32/5/32849\" title=\"picture 10\">",
"      AML FAB M6",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?38/9/39058\" title=\"picture 11\">",
"      AML FAB M7",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/86098|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?15/48/16141\" title=\"table 1\">",
"      FAB classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?36/38/37484\" title=\"table 2\">",
"      AML WHO criteria",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/15/26874?source=related_link\">",
"      Clinical features and diagnosis of Down syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/57/41882?source=related_link\">",
"      Clinical manifestations and diagnosis of the myelodysplastic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/58/20393?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of acute myeloid leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/12/200?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of acute promyelocytic leukemia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/42/39594?source=related_link\">",
"      Cytogenetics in acute myeloid leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/41/30362?source=related_link\">",
"      Induction therapy for acute myeloid leukemia in younger adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/11/28858?source=related_link\">",
"      Initial treatment of acute promyelocytic leukemia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/53/14168?source=related_link\">",
"      Overview of the complications of acute myeloid leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/33/35354?source=related_link\">",
"      Pathogenesis of acute myeloid leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/55/36730?source=related_link\">",
"      Prognosis of acute myeloid leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/35/39480?source=related_link\">",
"      Therapy-related myeloid neoplasms: Acute myeloid leukemia and myelodysplastic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/29/29146?source=related_link\">",
"      Treatment of acute myeloid leukemia in older adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_50_39721="Management of thromboembolic risk in patients with atrial fibrillation and chronic kidney disease";
var content_f38_50_39721=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of thromboembolic risk in patients with atrial fibrillation and chronic kidney disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/50/39721/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/50/39721/contributors\">",
"     Holger Reinecke, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/50/39721/contributors\">",
"     Daniela Kiski, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/50/39721/contributors\">",
"     Warren J Manning, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/50/39721/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/50/39721/contributors\">",
"     Bradley P Knight, MD, FACC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/50/39721/contributors\">",
"     Jeffrey S Berns, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/50/39721/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/50/39721/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/50/39721/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/50/39721/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 3, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H9066155\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of either atrial fibrillation (AF) or chronic kidney disease (CKD), defined as an estimated glomerular filtration rate (eGFR) &lt;60",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    , increases the risk of systemic thromboembolism and embolic (ischemic) stroke. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/23/27001?source=see_link&amp;anchor=H3#H3\">",
"     \"Risk of embolization in atrial fibrillation\", section on 'Incidence of embolism'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H1190658334\">",
"     'Stroke'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Antithrombotic therapy, which is recommended to decrease this risk for AF patients with one or more clinical risk factors for these adverse outcomes, and CKD are both associated with an increased risk of bleeding. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/17/42266?source=see_link&amp;anchor=H28#H28\">",
"     \"Therapeutic use of warfarin\", section on 'Bleeding'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H344020554\">",
"     'Major bleeding'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Thus, the decision to recommend antithrombotic therapy for patients with AF and CKD requires consideration of the benefit and risk. This is not an uncommon issue given the frequency of AF and CKD worldwide. Few studies have compared outcomes with different antithrombotic strategies in the subset of AF patients with CKD, and in particular those with end-stage renal disease, most of whom are receiving dialysis.",
"   </p>",
"   <p>",
"    This topic will present our approach to antithrombotic therapy across the spectrum of CKD severity. The approach to antithrombotic therapy in the broad population of patients with AF is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=see_link\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\"",
"    </a>",
"    .)",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H344021238\">",
"    <span class=\"h1\">",
"     PREVALENCE AND INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Estimates of the prevalence of CKD and AF, either alone or together, are as follows (",
"    <a class=\"graphic graphic_table graphicRef70227 \" href=\"mobipreview.htm?8/16/8460\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      CKD currently affects more than 15 million individuals in the United States, [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/1,2\">",
"       1,2",
"      </a>",
"      ]. Of these, approximately 530,000 have end-stage renal disease (ESRD), with as many as 370,000 receiving maintenance dialysis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The prevalence of AF in the general population is estimated to range between 0.4 to 1 percent depending on age, with a prevalence of about 8 percent among those over 80 years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/4\">",
"       4",
"      </a>",
"      ]. In the aggregate, over two million Americans are affected [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/5\">",
"       5",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/54/28522?source=see_link\">",
"       \"Epidemiology of and risk factors for atrial fibrillation\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/32/521?source=see_link\">",
"       \"Epidemiology of chronic kidney disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      AF is common in patients with CKD, particularly those with end-stage renal disease (ESRD). The prevalence of AF is between 8 to 34 percent in patients on hemodialysis and about 7 percent in patients undergoing peritoneal dialysis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/3,6,7\">",
"       3,6,7",
"      </a>",
"      ]. This rate is 10 to 20-fold higher than in the general population [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/8-11\">",
"       8-11",
"      </a>",
"      ]. Rates are higher in small studies which used repetitive 24-hour ECG Holter monitoring (",
"      <a class=\"graphic graphic_figure graphicRef55373 \" href=\"mobipreview.htm?34/0/34829\">",
"       figure 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/12-14\">",
"       12-14",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a study of over 206,229 adults with CKD without prior AF, 16,463 (8 percent) developed incident AF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/15\">",
"     15",
"    </a>",
"    ]. During a mean follow-up of about 5 years, there were 345 cases of ESRD that occurred after the development of AF (74 per 1000 person-years) in comparison with 6505 cases of ESRD during periods without AF (64 per 1000 person-years). After adjustment for potential confounders, incident AF was associated with a significant 67 percent increase in the rate of ESRD.",
"   </p>",
"   <p>",
"    In another study of over 250,000 United States patients over the age of 65 years who initiated dialysis between 1995 and 2007 and did not have AF at the start of treatment, the crude incidence rate for AF was 148 per 1000 person-years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/16\">",
"     16",
"    </a>",
"    ]. The incidence of AF increased significantly by 11 percent from 1995 to 2007.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1190657898\">",
"    <span class=\"h1\">",
"     ADVERSE OUTCOMES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1190658334\">",
"    <span class=\"h2\">",
"     Stroke",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stroke is a frequent complication in patients with CKD with or without AF. The mechanism of stroke includes both embolic and hemorrhagic events, although the former occurs four to six times more often [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of stroke increases as renal function declines. The following two studies are illustrative:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In an observational study of 1977 healthy individuals without ESRD, the hazard rate ratio for stroke in the subgroup with an eGFR of 40 to 70",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73 m",
"      <sup>",
"       2",
"      </sup>",
"      was 1.9, and 3.1 in those with an eGFR less than 40",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73 m",
"      <sup>",
"       2",
"      </sup>",
"      compared with those with an eGFR &gt;70",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73 m",
"      <sup>",
"       2",
"      </sup>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/18\">",
"       18",
"      </a>",
"      ] (",
"      <a class=\"graphic graphic_figure graphicRef68089 \" href=\"mobipreview.htm?11/15/11518\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      In the 2006 United States Renal Data System report, the annual incidence of stroke was 15 percent in hemodialysis patients compared to 10 percent in patients with earlier stages of CKD (",
"      <a class=\"graphic graphic_table graphicRef78831 \" href=\"mobipreview.htm?22/36/23115\">",
"       table 2",
"      </a>",
"      ), and less than 3 percent in control patients with normal renal function [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Among patients with AF, CKD is a powerful independent predictor of stroke, and the risk increases as renal function declines:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of nearly 11,000 AF patients with CKD who were not taking",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      , there was a graded, significantly increased risk of stroke associated with a progressively lower eGFR compared with an eGFR &ge;60",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73m",
"      <sup>",
"       2",
"      </sup>",
"      (relative risk 1.16 for an eGFR of 45 to 59",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73m",
"      <sup>",
"       2",
"      </sup>",
"      , and 1.39 for an eGFR less than 45",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73m",
"      <sup>",
"       2",
"      </sup>",
"      ) after adjustment for known risk factors for stroke [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In an analysis of patients not taking",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      in the Stroke Prevention and Atrial Fibrillation (SPAF)-3 trials, a lower eGFR as a continuous measure was independently predictive of events after adjusting for the individual CHADS2 risk factors (",
"      <a class=\"graphic graphic_table graphicRef61615 \" href=\"mobipreview.htm?39/45/40668\">",
"       table 3",
"      </a>",
"      ) in a multivariate model (hazard ratio 1.2 per 10 mL decrease, 95% CI 1.0-1.4) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/19\">",
"       19",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/29/39383?source=see_link&amp;anchor=H13#H13\">",
"       \"Stroke in patients with atrial fibrillation\", section on 'Warfarin'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/23/27001?source=see_link&amp;anchor=H9#H9\">",
"       \"Risk of embolization in atrial fibrillation\", section on 'Clinical parameters from randomized trials'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In a study of patients in the Danish national registries, there were 132,372 individuals discharged from a hospital with a diagnosis of AF between 1997 and 2008; 2.7 percent had non-end-stage CKD and 0.7 percent required renal replacement therapy at the time of inclusion [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/20\">",
"       20",
"      </a>",
"      ]. Compared to patients without CKD, the risk of stroke or systemic thromboembolism was increased in both groups (hazard ratios 1.49, 95% CI 1.38-1.59 and 1.83, 95% CI 1.57-2.14, respectively).",
"     </li>",
"     <li>",
"      The ROCKET AF trial (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=see_link&amp;anchor=H358919860#H358919860\">",
"       \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Rivaroxaban'",
"      </a>",
"      ), compared",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/16/5384?source=see_link\">",
"       rivaroxaban",
"      </a>",
"      to",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      in over 14,000 AF patients and included patients with a creatinine clearance (CrCl) &ge;30",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      (Cockcroft-Gault formula). The median CHADS2 (",
"      <a class=\"graphic graphic_table graphicRef61615 \" href=\"mobipreview.htm?39/45/40668\">",
"       table 3",
"      </a>",
"      ) and CHA2DS2-VASc (",
"      <a class=\"graphic graphic_table graphicRef83272 \" href=\"mobipreview.htm?30/23/31101\">",
"       table 4",
"      </a>",
"      ) scores were 3 and 5, indicating relatively high risk population. In a post hoc analysis, reduced CrCl was secondary only to prior stroke or transient ischemic attack among multiple variables thought to predict stroke or embolism [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/21\">",
"       21",
"      </a>",
"      ]. As a continuous variable, the hazard ratio for stroke or embolism increased 12 percent for each",
"      <span class=\"nowrap\">",
"       10-mL/min",
"      </span>",
"      decrease in renal function.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most models which predict the risk of stroke in patients with AF do not include CKD as a risk factor, in part because patients with CKD were not included in most of the randomized trials. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/23/27001?source=see_link\">",
"     \"Risk of embolization in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The presence of AF (compared with sinus rhythm), increases the risk of stroke (both ischemic and hemorrhagic) in most [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/7,22\">",
"     7,22",
"    </a>",
"    ], but not all [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/23,24\">",
"     23,24",
"    </a>",
"    ], series of patients with CKD, and rates between 17 and 24 percent per year have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/8\">",
"     8",
"    </a>",
"    ]. Studies may have come to differing conclusions due to different length of follow-up or intensity in the screening for and detection of AF and anticoagulation rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/8\">",
"     8",
"    </a>",
"    ]. In patients on dialysis with AF, the rate may be as high as 35 percent per year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9066183\">",
"    <span class=\"h2\">",
"     Mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the general population, the risk of death increases as renal function declines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/32/521?source=see_link&amp;anchor=H11#H11\">",
"     \"Epidemiology of chronic kidney disease\", section on 'Impact of CKD and ESRD on mortality'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The issue of whether the development of AF in patients with CKD further increases the risk of death is difficult to evaluate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/26\">",
"     26",
"    </a>",
"    ]. This is in part due to the strong association of AF with structural heart disease, the presence of which is associated with increased risk of death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/26\">",
"     26",
"    </a>",
"    ]. Patients who have ESRD and AF have an annual mortality of 5 percent compared with only 2 percent in those without AF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The cumulative two-year mortality rate after the appearance of stroke or transient ischemic attack is increased in CKD patients (55 and 41 percent, respectively, versus 25 percent in those without CKD) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/17\">",
"     17",
"    </a>",
"    ]. The rate is even higher in patients with ESRD (",
"    <a class=\"graphic graphic_figure graphicRef57454 \" href=\"mobipreview.htm?32/38/33389\">",
"     figure 3",
"    </a>",
"    ). Thus, the development of AF will likely decrease survival in patients with CKD. In this regard, one study found that (crude) three-year mortality rates of patients with ESRD who had been hospitalized for AF were significantly higher (53 percent, n = 123) than in the whole study cohort (45 percent, n = 3245) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/10\">",
"     10",
"    </a>",
"    ]. A longitudinal study (n = 190) reported four-year mortality rates of 81 percent in patients with AF, compared with only 29 percent in patients without AF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H344020554\">",
"    <span class=\"h2\">",
"     Major bleeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with CKD (particularly those receiving hemodialysis), compared to those without, are at increased risk of bleeding due to a number of pathophysiologic mechanisms (see",
"    <a class=\"local\" href=\"#H80534520\">",
"     'Bleeding risk'",
"    </a>",
"    below). This risk increases as the degree of CKD worsens. In a report of 578",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    treated patients with CKD, the risk of major hemorrhage was significantly greater in those with severe renal impairment (eGFR less than 30",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    ) than those with lesser degrees (relative risk 2.4, 95% CI 1.1-5.3) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    With regard to hemodialysis patients taking",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    :",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The rate of major bleeding ranged from 0.10 to 0.54 events per patient-year of exposure in a systematic review of small studies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/29\">",
"       29",
"      </a>",
"      ].",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       Warfarin",
"      </a>",
"      use was associated with a near doubling of the rate of bleeding [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/29,30\">",
"       29,30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Most bleeding events occur in the gastrointestinal tract [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In addition to the usual risk factors for bleeding (age, presence of comorbidities such as cardiovascular or liver disease), poor international normalized radio (INR) control or monitoring, or the concomitant use of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      are risk factors for bleeding [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/29,31\">",
"       29,31",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The impact of CKD on the risk of bleeding in patients with AF was evaluated in the large Danish registry study discussed above (see",
"    <a class=\"local\" href=\"#H1190658334\">",
"     'Stroke'",
"    </a>",
"    above) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/20\">",
"     20",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among all participants (with or without antithrombotic therapy), the risk of bleeding was higher for those with non-end-stage CKD and those requiring renal-replacement therapy compared to those with no renal disease (hazard ratios [HR] 2.24, 95% CI 2.10-2.38 and 2.70, 95% CI 2.38-3.07, respectively).",
"     </li>",
"     <li>",
"      Comparing patients with any renal disease to those without, there was an increased risk of bleeding with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      (HR 1.33, 95% CI 1.16-1.53),",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      (HR 1.17, 95% CI 1.02-1.34), or both (HR 1.61, 95% CI 1.32-1.96).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As has been shown in other studies, age &ge;65 years and a history of bleeding were strong predictors of bleeding in the Danish registry.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H80534491\">",
"    <span class=\"h2\">",
"     Pathophysiology of adverse outcomes",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H80534513\">",
"    <span class=\"h3\">",
"     Thromboembolic risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;The increased risk for ischemic stroke and thromboembolism in patients with AF is attributable to a predisposition to blood stasis, especially in the left atrial appendage and activation of the hemostatic system. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/32/43528?source=see_link\">",
"     \"Mechanisms of thrombogenesis in atrial fibrillation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/29/39383?source=see_link&amp;anchor=H2#H2\">",
"     \"Stroke in patients with atrial fibrillation\", section on 'Stroke characteristics'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The increased risk for these adverse outcomes in patients with CKD is due to alterations in the normal hemostatic mechanisms. (see",
"    <a class=\"local\" href=\"#H1190658334\">",
"     'Stroke'",
"    </a>",
"    above). Additional factors include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients on hemodialysis suffer from changes between hypervolemia, and intravascular volume loss within a few hours (which may increase blood viscosity), combined with changes in electrolytes during the hemodialysis procedure.",
"     </li>",
"     <li>",
"      Increased atherosclerosis and endothelial damage.",
"     </li>",
"     <li>",
"      Activation of the renin-angiotensin-aldosterone system.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients on dialysis who do not have AF are also at increased risk due to alterations in the physiologic mechanisms that maintain normal hemostasis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/8,32,33\">",
"     8,32,33",
"    </a>",
"    ] (",
"    <a class=\"graphic graphic_table graphicRef80195 \" href=\"mobipreview.htm?20/62/21484\">",
"     table 5",
"    </a>",
"    ). Thus, patients in all",
"    <strong>",
"    </strong>",
"    stages of CKD (",
"    <a class=\"graphic graphic_table graphicRef78831 \" href=\"mobipreview.htm?22/36/23115\">",
"     table 2",
"    </a>",
"    ), but especially those on hemodialysis, suffer from a prothrombotic status due to changes in protein C metabolism, glycoprotein Ib expression, activator inhibitor-1 to tissue-type plasminogen activator ratio and plasmin inhibition by lipoprotein(a) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/8,17,27,33-36\">",
"     8,17,27,33-36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H80534520\">",
"    <span class=\"h3\">",
"     Bleeding risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;CKD is associated with an increased risk of bleeding complications, particularly from the gastrointestinal tract. Pathophysiologic mechanisms include impairment of normal platelet function secondary to factors such as uremic toxins, abnormal platelet arachidonic acid metabolism, altered von Willebrand factor, and reduction in intracellular ADP and serotonin, as well as an increase in the frequency of the need for invasive procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/30/10727?source=see_link\">",
"     \"Platelet dysfunction in uremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9066197\">",
"    <span class=\"h1\">",
"     BENEFITS AND RISKS OF ORAL ANTITHROMBOTIC THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the general population of patients with non-valvular AF, the benefit from oral antithrombotic therapy for the prevention of stroke and peripheral embolism is usually greater than the risk of increased bleeding, except in patients with no risk factors for thromboembolism using the CHADS2 scoring system (CHADS2 score of 0) (",
"    <a class=\"graphic graphic_table graphicRef61615 \" href=\"mobipreview.htm?39/45/40668\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=see_link&amp;anchor=H7#H7\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Efficacy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most of the randomized trials of antithrombotic therapy have included AF patients with an eGFR as low as 30",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    . As a result, we believe there is high quality evidence to support the use of antithrombotic therapy in such patients who have a CHADS2 score of 1 or more (",
"    <a class=\"graphic graphic_table graphicRef61615 \" href=\"mobipreview.htm?39/45/40668\">",
"     table 3",
"    </a>",
"    ). Data are limited on patients with an eGFR less than 30",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=see_link&amp;anchor=H5#H5\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Antithrombotic prevention'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This section will present our approach to antithrombotic therapy in patients with CKD and AF. The following two points should be kept in mind when treating such patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oral anticoagulant therapy is preferred to antiplatelet therapy in all patient groups addressed in this topic. This issue is discussed in detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=see_link&amp;anchor=H31#H31\">",
"       \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Summary and recommendations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Although many of the available studies evaluated the efficacy and safety of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      , more recent trials have evaluated newer agents such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/39/8825?source=see_link\">",
"       dabigatran",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/62/39911?source=see_link\">",
"       apixaban",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/16/5384?source=see_link\">",
"       rivaroxaban",
"      </a>",
"      .",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1452068058\">",
"    <span class=\"h2\">",
"     eGFR 30 to 59 mL/min per 1.73 m2 (stage 3 CKD)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The older trials comparing",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    to placebo did not evaluate outcomes specifically in the subgroup of patient with stage 3 CKD. Thus, while we believe that this subgroup achieved the same benefit from warfarin as the entire cohort, we cannot be highly confident of this.",
"   </p>",
"   <p>",
"    There are three, large randomized trials &mdash; RE-LY, ARISTOTLE, and ROCKET-AF &mdash; that, in subgroup analyses, evaluated the efficacy and safety of oral antithrombotic therapy in patients with stage 3 CKD (",
"    <a class=\"graphic graphic_table graphicRef78831 \" href=\"mobipreview.htm?22/36/23115\">",
"     table 2",
"    </a>",
"    ). All three trials compared newer antithrombotic agents to adjusted dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    (target INR 2.0-3.0) for the prevention of stroke and systemic embolism. In all three trials, the subgroup analyses found similar outcomes in the subgroup of patients with stage 3 CKD and in the entire study population:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In RE-LY,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/39/8825?source=see_link\">",
"       dabigatran",
"      </a>",
"      was superior to",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      at a 150 mg dose and noninferior to warfarin at a 110 mg dose [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/37\">",
"       37",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=see_link&amp;anchor=H4338483#H4338483\">",
"       \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Dabigatran'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In ARISTOTLE,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/62/39911?source=see_link\">",
"       apixaban",
"      </a>",
"      (5 mg twice daily) was superior to",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/38\">",
"       38",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=see_link&amp;anchor=H147982962#H147982962\">",
"       \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Apixaban'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In ROCKET-AF,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/16/5384?source=see_link\">",
"       rivaroxaban",
"      </a>",
"      (20 mg once daily, or 15 mg daily in patients with a creatinine clearance of 30 to 49",
"      <span class=\"nowrap\">",
"       mL/min)",
"      </span>",
"      was noninferior to",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      , [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/39\">",
"       39",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=see_link&amp;anchor=H358919860#H358919860\">",
"       \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Rivaroxaban'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In ARISTOTLE and ROCKET-AF, the incidence of embolic events was higher in the patients with stage 3 CKD (",
"    <a class=\"graphic graphic_table graphicRef78831 \" href=\"mobipreview.htm?22/36/23115\">",
"     table 2",
"    </a>",
"    ) irrespective of anticoagulant used. In ARISTOTLE for example, the rates",
"    <span class=\"nowrap\">",
"     (percent/year)",
"    </span>",
"    of the primary outcome comparing",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/62/39911?source=see_link\">",
"     apixaban",
"    </a>",
"    to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    were 1.3 versus 1.6 in the entire cohort, 1.0 versus 1.1 in those with no renal impairment, 1.2 versus 1.7 in those with mild renal impairment, and 2.1 versus 2.7 in those with severe or moderate renal impairment.",
"   </p>",
"   <p>",
"    There were few patients without risk factors for arterial thromboembolism (CHADS2 of 0) enrolled in randomized trials of anticoagulant therapy in AF patients. As discussed above, CKD increases the risk of thromboembolism independent of other risk factors (see",
"    <a class=\"local\" href=\"#H1190658334\">",
"     'Stroke'",
"    </a>",
"    above), as well as the risk of bleeding (see",
"    <a class=\"local\" href=\"#H344020554\">",
"     'Major bleeding'",
"    </a>",
"    above). We believe that some of these patients will choose antithrombotic therapy if informed of the potential benefits and risks. Thus, we make a weak recommendation for antithrombotic therapy for AF patients with an eGFR between 30 and 59",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    and a CHADS2 score of 0.",
"   </p>",
"   <p>",
"    Some, but not all, of the authors and reviewers of this topic prefer oral anticoagulant to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    based upon the superiority of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    to aspirin in all the randomized trials. They consider aspirin as a reasonable alternative for individual patients, who may be willing to accept a smaller benefit in exchange for a lesser degree risk of bleeding. Others feel that aspirin or oral anticoagulant are both reasonable choices.",
"   </p>",
"   <p>",
"    For those patients with an eGFR 30 to 59",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    in whom oral anticoagulant therapy is chosen, irrespective of a CHADS2 score, we prefer either a factor Xa or direct thrombin inhibitor to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    . The supportive data are presented in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=see_link&amp;anchor=H147982501#H147982501\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Studies of anticoagulant monotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H337817722\">",
"    <span class=\"h2\">",
"     eGFR between 15 and 29 mL/min per 1.73 m2 (stage 4 CKD)",
"    </span>",
"    &nbsp;&mdash;&nbsp;As the degree of CKD worsens, the rates of both stroke and bleeding increase (see",
"    <a class=\"local\" href=\"#H80534491\">",
"     'Pathophysiology of adverse outcomes'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H344020554\">",
"     'Major bleeding'",
"    </a>",
"    above). However, the absolute rates are not well defined in patients with severe CKD, which is defined as an eGFR between 15 and 29",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    (stage 4 CKD). In addition, only a small number of patients in clinical trials had an eGFR between 15 and 29",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73m",
"    <sup>",
"     2",
"    </sup>",
"    (stage 4 CKD). In the Stroke Prevention and Atrial Fibrillation (SPAF) trials, about 2 percent of patients had stage 4 CKD (",
"    <a class=\"graphic graphic_table graphicRef78831 \" href=\"mobipreview.htm?22/36/23115\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/40\">",
"     40",
"    </a>",
"    ]. Thus, we cannot be as certain about the absolute clinical benefit from antithrombotic therapy in CKD patients as we can for the general population.",
"   </p>",
"   <p>",
"    We believe that anticoagulant therapy has a net clinical benefit (the decrease in embolic events is greater than the increase in bleeding events) in patients with stage 4 CKD (",
"    <a class=\"graphic graphic_table graphicRef78831 \" href=\"mobipreview.htm?22/36/23115\">",
"     table 2",
"    </a>",
"    ) and recommend its use in patients not deemed to be at high bleeding risk (",
"    <a class=\"graphic graphic_table graphicRef59051 \" href=\"mobipreview.htm?32/58/33707\">",
"     table 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef75259 \" href=\"mobipreview.htm?38/14/39148\">",
"     table 7",
"    </a>",
"    ) (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/17/42266?source=see_link\">",
"     \"Therapeutic use of warfarin\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/17/42266?source=see_link&amp;anchor=H28#H28\">",
"     \"Therapeutic use of warfarin\", section on 'Bleeding'",
"    </a>",
"    ). This recommendation is made irrespective of a CHADS2 score.",
"   </p>",
"   <p>",
"    Any discussion of the potential use of antithrombotic therapy in such patients should include comments regarding the increase in bleeding risk. Reasons to consider withholding anticoagulant therapy are discussed below. (See",
"    <a class=\"local\" href=\"#H16443209\">",
"     'Patients for whom withholding antithrombotic therapy is reasonable'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    With regard to the choice of anticoagulant in these patients, we prefer",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    as opposed to other oral anticoagulants. This is based on the fact that there is a wide clinical experience with warfarin in these patients and that patients with an eGFR of less than 30",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    were almost entirely excluded from the randomized trials of newer oral anticoagulants.",
"   </p>",
"   <p>",
"    Based upon pharmacokinetic modeling, the Food and Drug Administration in the United States approved",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/39/8825?source=see_link\">",
"     dabigatran",
"    </a>",
"    at a dose of 75 mg twice daily for these patients. Since there are no randomized clinical data using this regimen or any other dabigatran regimen in patients with state 4 CKD, we do not recommend the use of dabigatran in this setting. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=see_link&amp;anchor=H4338483#H4338483\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Dabigatran'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We believe that for these individuals at high risk of stroke, we prefer oral anticoagulation to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , given the greater efficacy of the former.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H337817747\">",
"    <span class=\"h2\">",
"     eGFR less than 15 mL/min per 1.73m2 (stage 5 CKD)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Our uncertainty regarding the net clinical benefit of anticoagulant therapy is particularly high in patients with an eGFR less than 15",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    (stage 5 CKD) (",
"    <a class=\"graphic graphic_table graphicRef70227 \" href=\"mobipreview.htm?8/16/8460\">",
"     table 1",
"    </a>",
"    ), given the absence of relevant randomized trial data as well as the markedly increased risk of bleeding in these patients. In addition, the need for repetitive arteriovenous fistula access creates another potential source for bleeding complications. (See",
"    <a class=\"local\" href=\"#H344020554\">",
"     'Major bleeding'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H80534520\">",
"     'Bleeding risk'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The safety of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    in patients with end stage renal disease (ESRD) has been evaluated in a few observational studies, which have come to differing conclusions. Each of these has potential significant sources of bias:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Two retrospective analyses of (1671 and 3245) hemodialysis patients with AF raised the possibility of an increased risk of stroke (both ischemic and hemorrhagic) in patients treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      compared to those not treated [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/41,42\">",
"       41,42",
"      </a>",
"      ]. In one of these studies, the risk was increased nearly twofold (HR 1.93, 95% CI 1.29-2.90) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a report from the US Renal Data System, survival of patients with ESRD receiving tissue and non-tissue prosthetic heart valves was compared [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/43\">",
"       43",
"      </a>",
"      ]. There was no significant difference between the survival rates of the 5000 patients receiving mechanical valves (and oral anticoagulation) compared to the about 900 individuals who received tissue valves, but who likely did not take oral anticoagulants.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We suggest oral anticoagulation for AF patients with a CHADS2 score of 1 or higher who have ESRD to decrease the risk of stroke if there is no history of intracranial hemorrhage and no major risks for bleeding (eg, liver disease, active malignancy, or predisposition to falls) are present. For AF patients with ESRD and other high risk predictors for thromboembolism, such as known atrial thrombus, prosthetic heart valve (particularly in the mitral position), mitral stenosis, previous transient ischemic attack or stroke, the risk to benefit ratio of anticoagulation may be clearly in favor of such therapy even if the bleeding risk is high [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    ESRD patients with a CHADS2 score of 0 are rare. For these patients some of our experts recommend",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    , while others do not.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16443209\">",
"    <span class=\"h2\">",
"     Patients for whom withholding antithrombotic therapy is reasonable",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given our uncertainty of the benefit to risk ratio of antithrombotic therapy in AF patients with an eGFR less than 30",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    , it is reasonable to not recommend antithrombotic therapy in the follow groups of individuals:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with a strong preference for no antithrombotic therapy, after a full discussion of the benefits and risk",
"     </li>",
"     <li>",
"      Patients at high fall risk",
"     </li>",
"     <li>",
"      Patients with prior life threatening bleeding",
"     </li>",
"     <li>",
"      Patients with poorly controlled hypertension",
"     </li>",
"     <li>",
"      Patients with a low likelihood of successful INR control",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H412283\">",
"    <span class=\"h2\">",
"     Other considerations",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9066211\">",
"    <span class=\"h3\">",
"     Parenteral anticoagulants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Potential alternatives to oral anticoagulants for patients with moderate to severe CKD include parenteral anticoagulants such as low-molecular weight heparins and heparinoids like",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/18/41254?source=see_link\">",
"     danaparoid",
"    </a>",
"    . Most of these show a clear tendency to accumulate, especially in patients with advanced stages of CKD (",
"    <a class=\"graphic graphic_table graphicRef78831 \" href=\"mobipreview.htm?22/36/23115\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/44-47\">",
"     44-47",
"    </a>",
"    ]. We do not use these agents in our practices.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H344020228\">",
"    <span class=\"h3\">",
"     Warfarin dose and INR monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal international normalized ratio range for patients with CKD is 2.0 to 3.0. In addition, as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    is metabolized mainly by the liver, there are no recommendations to alter warfarin dose in patients with CKD (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/17/42266?source=see_link\">",
"     \"Therapeutic use of warfarin\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/8/30857?source=see_link\">",
"     \"Correcting excess anticoagulation after warfarin\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    However, observations of higher rates of bleeding in patients with ESRD taking",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    compared to those with lesser degrees of renal dysfunction have raised the possibility of an influence of CKD on warfarin dosing. The relationship between kidney function and warfarin dose was evaluated in a study of 565 patients stratified by baseline renal function (eGFR &ge;60, 30 to 59, or less than 30",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    ). After adjustment for clinical and genetic factors, patients with severe CKD had significantly lower warfarin dosage requirements compared to those with lesser degrees of renal impairment (3.9, 4.3, and 4.8",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/28\">",
"     28",
"    </a>",
"    ]. In addition, the proportion of INR values in the target range was significantly lower in those with more impaired renal function (46, 46 and 50 percent respectively). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=see_link&amp;anchor=H11#H11\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'INR monitoring and goal'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Lower eGFRs are associated with poorer anticoagulation control (proportion of out of range INRs) and a significantly higher rate of major bleeding (risk ratio 3.7, 95% CI 1.8-7.2 comparing severe to moderate CKD groups).",
"   </p>",
"   <p>",
"    During the first 30 to 90 days on",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    , the risk for hemorrhagic events is markedly increased [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/34,41,48-50\">",
"     34,41,48-50",
"    </a>",
"    ]. The reason for this may be that warfarin therapy is often started too aggressively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/41,48,51\">",
"     41,48,51",
"    </a>",
"    ], which results in higher than intended INRs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/27,41,48\">",
"     27,41,48",
"    </a>",
"    ]. Moreover, these bleeding events in the early phase may be caused by some patient-inherent factors (eg, microangiopathy of cerebral arteries). This implies that those who have already taken warfarin for at least 90 days without any major bleeding complications may be a lower risk group with a smaller risk for future hemorrhagic events [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/48-51\">",
"     48-51",
"    </a>",
"    ]. Based on the increase in risk of bleeding during the early period of anticoagulation with warfarin, we suggest reducing the starting warfarin dose to 2.5 mg daily for two days for patients with AF and an eGFR less than 30",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    . This issue is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/17/42266?source=see_link&amp;anchor=H23#H23\">",
"     \"Therapeutic use of warfarin\", section on 'Initial dose'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We suggest monitoring the INR several times per week during at least the first few weeks of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    therapy to facilitate safety. With regard to the high rate of bleedings during the first one to three months of the oral anticoagulant (OAC) therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/50/39721/abstract/34,41,48-50\">",
"     34,41,48-50",
"    </a>",
"    ], self monitoring may provide a marked improvement in safety. For those patients not able to self monitor, practitioners should monitor the INR in short intervals. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/2/35880?source=see_link\">",
"     \"Outpatient management of oral anticoagulation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/2/35880?source=see_link&amp;anchor=H4#H4\">",
"     \"Outpatient management of oral anticoagulation\", section on 'Self-monitoring and self-management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H358920819\">",
"    <span class=\"h3\">",
"     Patients taking aspirin",
"    </span>",
"    &nbsp;&mdash;&nbsp;For most patients taking oral anticoagulation with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    (and presumably",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/39/8825?source=see_link\">",
"     dabigatran",
"    </a>",
"    ), there appears to be little additional protection for the prevention of cardiovascular disease from",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    therapy. Combined therapy may be reasonable in selected patients with coronary heart disease, such as those with acute coronary syndromes or those who receive coronary stents. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=see_link&amp;anchor=H27#H27\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Patients on long-term antiplatelet therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As the risk of major bleeding in ESRD patients taking oral anticoagulation is very high, the combined use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , or other antiplatelet therapy such as a thienopyridine, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    should be undertaken with caution.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9066239\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chronic kidney disease (CKD), defined as an estimated glomerular filtration rate (eGFR) less than 60",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73 m",
"      <sup>",
"       2",
"      </sup>",
"      ,",
"      <sup>",
"      </sup>",
"      and atrial fibrillation (AF) are both individual risk factors for stroke. In patients with both CKD and AF, the risk exceeds that if only one of the two is present. (See",
"      <a class=\"local\" href=\"#H1190658334\">",
"       'Stroke'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with CKD, particularly those with end stage renal disease (an estimated glomerular filtration rate [eGFR] less than 15",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73 m",
"      <sup>",
"       2",
"      </sup>",
"      ), are at increased risk of bleeding. This risk is further increased with the use of anticoagulant therapy. (See",
"      <a class=\"local\" href=\"#H344020554\">",
"       'Major bleeding'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the general population of patients with AF, antithrombotic therapy is recommended for most of those with risk factors for stroke and systemic embolization (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=see_link&amp;anchor=H31#H31\">",
"       \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Summary and recommendations'",
"      </a>",
"      ). As randomized trials which support this recommendation included patients with an eGFR as low as 30",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73 m",
"      <sup>",
"       2",
"      </sup>",
"      , we are moderately confident that recommendations made for the general population of patients with AF apply to these individuals (see",
"      <a class=\"local\" href=\"#H1452068058\">",
"       'eGFR 30 to 59 mL/min per 1.73 m2 (stage 3 CKD)'",
"      </a>",
"      above).",
"      <br/>",
"      <br/>",
"      However, as very few patients with an eGFR less than 30",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.7 m",
"      <sup>",
"       2",
"      </sup>",
"      have been enrolled in these clinical trials, we are less certain about the relationship between efficacy and safety in these individuals.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7220242\">",
"    <span class=\"h2\">",
"     eGFR 30 to 59 mL/min per 1.73 m2",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For AF patients with an eGFR 30 to 59",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73 m",
"      <sup>",
"       2",
"      </sup>",
"      and a CHADS2 score of 1 or higher (",
"      <a class=\"graphic graphic_table graphicRef61615 \" href=\"mobipreview.htm?39/45/40668\">",
"       table 3",
"      </a>",
"      ), we recommend chronic anticoagulant therapy (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=see_link&amp;anchor=H5#H5\">",
"       \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Antithrombotic prevention'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      For these patients with a CHADS2 score of 0, we suggest chronic anticoagulant or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      rather than no antithrombotic agent (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Some of our experts prefer oral anticoagulant in this setting while others feel that either aspirin or oral anticoagulant is a reasonable choice. (See",
"      <a class=\"local\" href=\"#H1452068058\">",
"       'eGFR 30 to 59 mL/min per 1.73 m2 (stage 3 CKD)'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Patients may reasonably choose no antithrombotic therapy based on either their concerns for an increase in bleeding risk or other factors. (See",
"      <a class=\"local\" href=\"#H1452068058\">",
"       'eGFR 30 to 59 mL/min per 1.73 m2 (stage 3 CKD)'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/17/42266?source=see_link&amp;anchor=H29#H29\">",
"       \"Therapeutic use of warfarin\", section on 'Major risk factors'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In patients for whom anticoagulant therapy is chosen, we recommend a direct thrombin inhibitor or a factor Xa inhibitor rather than",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10515784\">",
"    <span class=\"h2\">",
"     eGFR between 15 and 29 mL/min per 1.73 m2",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       For AF patients with an eGFR between 15 and 29",
"       <span class=\"nowrap\">",
"        mL/min",
"       </span>",
"       per 1.73 m",
"      </strong>",
"      <strong>",
"       <sup>",
"        2",
"       </sup>",
"      </strong>",
"      <strong>",
"       and a CHADS2",
"      </strong>",
"      of 1 or greater,",
"      <strong>",
"      </strong>",
"      we suggest anticoagulant therapy, as opposed to no anticoagulant therapy (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      For these patients with a",
"      <strong>",
"       CHADS2 of 0",
"      </strong>",
"      (who are rare), some of our authors and reviewers recommend",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      while others do",
"      <strong>",
"      </strong>",
"      not. Other patients in whom it may be reasonable to not choose antithrombotic therapy are presented above. (See",
"      <a class=\"local\" href=\"#H16443209\">",
"       'Patients for whom withholding antithrombotic therapy is reasonable'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For these patients in whom chronic anticoagulant therapy is chosen, we recommend",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      as opposed",
"      <strong>",
"      </strong>",
"      to other anticoagulants (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H337817722\">",
"       'eGFR between 15 and 29 mL/min per 1.73 m2 (stage 4 CKD)'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10515831\">",
"    <span class=\"h2\">",
"     ESRD",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For AF patients with ESRD and a CHADS2 score of 1 or higher, we suggest anticoagulant therapy with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      as opposed to no anticoagulant therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      For patients with ESRD and a CHADS2 score of 0, some of our experts recommend anticoagulant therapy with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      , while others do not. Other patients in whom it may be reasonable to not choose antithrombotic therapy are presented above. (See",
"      <a class=\"local\" href=\"#H16443209\">",
"       'Patients for whom withholding antithrombotic therapy is reasonable'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H54646869\">",
"    <span class=\"h2\">",
"     Warfarin Dosing",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with AF and an eGFR less than 30",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    , we suggest reducing the starting dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    to 2.5 mg daily, based on an increase in the risk of bleeding during the early period of anticoagulation with warfarin. In addition, the international normalized ratio should be monitored more frequently than usual, particularly during the first 90 days. (See",
"    <a class=\"local\" href=\"#H344020228\">",
"     'Warfarin dose and INR monitoring'",
"    </a>",
"    above.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/1\">",
"      Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med 2006; 354:997.",
"     </a>",
"    </li>",
"    <li>",
"     Frei, U, Schober-Halstenberg, HJ. Nierenersatztherapie in Deutschland. QuaSi-Niere Jahresbericht 2005/2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/3\">",
"      Winkelmayer WC, Patrick AR, Liu J, et al. The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol 2011; 22:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/4\">",
"      European Heart Rhythm Association, Heart Rhythm Society, Fuster V, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2006; 48:854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/5\">",
"      Go AS, Fang MC, Udaltsova N, et al. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation 2009; 119:1363.",
"     </a>",
"    </li>",
"    <li>",
"     US Renal Data System: USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes, and Digestive and Kidney Diseases, 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/7\">",
"      Yang F, Chou D, Schweitzer P, Hanon S. Warfarin in haemodialysis patients with atrial fibrillation: what benefit? Europace 2010; 12:1666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/8\">",
"      Marinigh R, Lane DA, Lip GY. Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk. J Am Coll Cardiol 2011; 57:1339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/9\">",
"      Atar I, Kona�� D, A&ccedil;ikel S, et al. Frequency of atrial fibrillation and factors related to its development in dialysis patients. Int J Cardiol 2006; 106:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/10\">",
"      Abbott KC, Trespalacios FC, Taylor AJ, Agodoa LY. Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality. BMC Nephrol 2003; 4:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/11\">",
"      K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005; 45:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/12\">",
"      V&aacute;zquez E, S&aacute;nchez-Perales C, Borrego F, et al. Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J 2000; 140:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/13\">",
"      Bozbas H, Atar I, Yildirir A, et al. Prevalence and predictors of arrhythmia in end stage renal disease patients on hemodialysis. Ren Fail 2007; 29:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/14\">",
"      Genovesi S, Pogliani D, Faini A, et al. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 2005; 46:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/15\">",
"      Bansal N, Fan D, Hsu CY, et al. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation 2013; 127:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/16\">",
"      Goldstein BA, Arce CM, Hlatky MA, et al. Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. Circulation 2012.",
"     </a>",
"    </li>",
"    <li>",
"     US Renal Data System: USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes, and Digestive and Kidney Diseases, 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/18\">",
"      Nakayama M, Metoki H, Terawaki H, et al. Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population--the Ohasama study. Nephrol Dial Transplant 2007; 22:1910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/19\">",
"      Hart RG, Pearce LA, Asinger RW, Herzog CA. Warfarin in atrial fibrillation patients with moderate chronic kidney disease. Clin J Am Soc Nephrol 2011; 6:2599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/20\">",
"      Olesen JB, Lip GY, Kamper AL, et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 2012; 367:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/21\">",
"      Piccini JP, Stevens SR, Chang Y, et al. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation 2013; 127:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/22\">",
"      Vazquez E, Sanchez-Perales C, Garcia-Garcia F, et al. Atrial fibrillation in incident dialysis patients. Kidney Int 2009; 76:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/23\">",
"      Genovesi S, Vincenti A, Rossi E, et al. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Am J Kidney Dis 2008; 51:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/24\">",
"      Bos MJ, Koudstaal PJ, Hofman A, Breteler MM. Decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke: the Rotterdam Study. Stroke 2007; 38:3127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/25\">",
"      Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/26\">",
"      Reinecke H, Brand E, Mesters R, et al. Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol 2009; 20:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/27\">",
"      V&aacute;zquez E, S&aacute;nchez-Perales C, Lozano C, et al. Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis. Am J Cardiol 2003; 92:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/28\">",
"      Limdi NA, Beasley TM, Baird MF, et al. Kidney function influences warfarin responsiveness and hemorrhagic complications. J Am Soc Nephrol 2009; 20:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/29\">",
"      Elliott MJ, Zimmerman D, Holden RM. Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates. Am J Kidney Dis 2007; 50:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/30\">",
"      V&aacute;zquez E, S&aacute;nchez-Perales C, Garc&iacute;a-Cortes MJ, et al. Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants? Int J Cardiol 2003; 87:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/31\">",
"      Holden RM, Harman GJ, Wang M, et al. Major bleeding in hemodialysis patients. Clin J Am Soc Nephrol 2008; 3:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/32\">",
"      Kaw D, Malhotra D. Platelet dysfunction and end-stage renal disease. Semin Dial 2006; 19:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/33\">",
"      Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure. Semin Thromb Hemost 2004; 30:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/34\">",
"      Falg&aacute; C, Capdevila JA, Soler S, et al. Clinical outcome of patients with venous thromboembolism and renal insufficiency. Findings from the RIETE registry. Thromb Haemost 2007; 98:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/35\">",
"      Tveit DP, Hypolite IO, Hshieh P, et al. Chronic dialysis patients have high risk for pulmonary embolism. Am J Kidney Dis 2002; 39:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/36\">",
"      Gangji AS, Sohal AS, Treleaven D, Crowther MA. Bleeding in patients with renal insufficiency: a practical guide to clinical management. Thromb Res 2006; 118:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/37\">",
"      Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/38\">",
"      Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/39\">",
"      Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/40\">",
"      Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996; 348:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/41\">",
"      Chan KE, Lazarus JM, Thadhani R, Hakim RM. Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol 2009; 20:2223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/42\">",
"      Wizemann V, Tong L, Satayathum S, et al. Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int 2010; 77:1098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/43\">",
"      Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients in the United States with prosthetic heart valves: should ACC/AHA practice guidelines on valve selection be modified? Circulation 2002; 105:1336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/44\">",
"      Lo DS, Rabbat CG, Clase CM. Thromboembolism and anticoagulant management in hemodialysis patients: a practical guide to clinical management. Thromb Res 2006; 118:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/45\">",
"      Farooq V, Hegarty J, Chandrasekar T, et al. Serious adverse incidents with the usage of low molecular weight heparins in patients with chronic kidney disease. Am J Kidney Dis 2004; 43:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/46\">",
"      Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126:188S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/47\">",
"      DeCarolis DD, Thorson JG, Clairmont MA, et al. Enoxaparin outcomes in patients with moderate renal impairment. Arch Intern Med 2012; 172:1713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/48\">",
"      Hylek EM, Evans-Molina C, Shea C, et al. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 2007; 115:2689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/49\">",
"      Wyse DG. Bleeding while starting anticoagulation for thromboembolism prophylaxis in elderly patients with atrial fibrillation: from bad to worse. Circulation 2007; 115:2684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/50\">",
"      Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med 2003; 139:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/50/39721/abstract/51\">",
"      Ritz E. Minor renal dysfunction: an emerging independent cardiovascular risk factor. Heart 2003; 89:963.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14030 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.1.191.153-8DAC4F1F78-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_50_39721=[""].join("\n");
var outline_f38_50_39721=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H9066239\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9066155\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H344021238\">",
"      PREVALENCE AND INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1190657898\">",
"      ADVERSE OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1190658334\">",
"      Stroke",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9066183\">",
"      Mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H344020554\">",
"      Major bleeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H80534491\">",
"      Pathophysiology of adverse outcomes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H80534513\">",
"      - Thromboembolic risk",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H80534520\">",
"      - Bleeding risk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9066197\">",
"      BENEFITS AND RISKS OF ORAL ANTITHROMBOTIC THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1452068058\">",
"      eGFR 30 to 59 mL/min per 1.73 m2 (stage 3 CKD)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H337817722\">",
"      eGFR between 15 and 29 mL/min per 1.73 m2 (stage 4 CKD)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H337817747\">",
"      eGFR less than 15 mL/min per 1.73m2 (stage 5 CKD)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16443209\">",
"      Patients for whom withholding antithrombotic therapy is reasonable",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H412283\">",
"      Other considerations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9066211\">",
"      - Parenteral anticoagulants",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H344020228\">",
"      - Warfarin dose and INR monitoring",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H358920819\">",
"      - Patients taking aspirin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9066239\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7220242\">",
"      eGFR 30 to 59 mL/min per 1.73 m2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10515784\">",
"      eGFR between 15 and 29 mL/min per 1.73 m2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10515831\">",
"      ESRD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H54646869\">",
"      Warfarin Dosing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/14030\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/14030|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?34/0/34829\" title=\"figure 1\">",
"      Prevalence of atrial fibrillation in CKD pts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?11/15/11518\" title=\"figure 2\">",
"      Relative risk of stroke in chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?32/38/33389\" title=\"figure 3\">",
"      Cumulative two year mortality rates in CKD pts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/14030|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/16/8460\" title=\"table 1\">",
"      Prevalence of stages of CKD in the US",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?22/36/23115\" title=\"table 2\">",
"      Stages of chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?39/45/40668\" title=\"table 3\">",
"      CHADS2 score and thromboembolic risk with and without warfarin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?30/23/31101\" title=\"table 4\">",
"      CHA2DS2-VASc score and stroke risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?20/62/21484\" title=\"table 5\">",
"      CKD factors that affect hemostasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?32/58/33707\" title=\"table 6\">",
"      Bleeding risk index warfarin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?38/14/39148\" title=\"table 7\">",
"      HAS-BLED risk score",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=related_link\">",
"      Antithrombotic therapy to prevent embolization in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/8/30857?source=related_link\">",
"      Correcting excess anticoagulation after warfarin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/54/28522?source=related_link\">",
"      Epidemiology of and risk factors for atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/32/521?source=related_link\">",
"      Epidemiology of chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/32/43528?source=related_link\">",
"      Mechanisms of thrombogenesis in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/2/35880?source=related_link\">",
"      Outpatient management of oral anticoagulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/30/10727?source=related_link\">",
"      Platelet dysfunction in uremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/23/27001?source=related_link\">",
"      Risk of embolization in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/29/39383?source=related_link\">",
"      Stroke in patients with atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/17/42266?source=related_link\">",
"      Therapeutic use of warfarin",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_50_39722="Vitiligo - elbow";
var content_f38_50_39722=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F74712%7EDERM%2F51865%7EDERM%2F53173%7EPC%2F62050%7EDERM%2F63623&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F74712%7EDERM%2F51865%7EDERM%2F53173%7EPC%2F62050%7EDERM%2F63623&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vitiligo",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An irregularly shaped hypopigmented patch is present on the elbow.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vitiligo",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Depigmented patches are present on the lips of this patient with vitiligo.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vitiligo",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A depigmented patch of vitiligo is present on the periocular skin. Note associated loss of pigment in the eyebrow and eyelashes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vitiligo",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 387px; height: 264px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the depigmented skin around the anus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Beth G Goldstein, MD, and Adam O Goldstein, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vitiligo",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple depigmented macules and patches are present on the hands.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_50_39722=[""].join("\n");
var outline_f38_50_39722=null;
var title_f38_50_39723="Mechanism exercise on mortality";
var content_f38_50_39723=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F51658&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F51658&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Possible biologic mechanisms for exercise-induced reductions in all-cause and cardiac mortality",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Cardiovascular influences",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduction of resting and exercise heart rate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduction of resting and exercise blood pressure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduction of myocardial oxygen demand at submaximal levels of physical activity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Expansion of plasma volume",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increase in myocardial contractility",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increase in peripheral venous tone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Favorable changes in fibrinolytic system",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased endothelium-dependent vasodilation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased gene expression for nitric oxide synthase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Enhanced parasympathetic tone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Possible increases in coronary blood flow, coronary collateral vessels, and myocardial capillary density",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Metabolic influences",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduction of obesity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Enhanced glucose tolerance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Improved lipid profile",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Lifestyle influences",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Decreased liklihood of smoking",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Possible reduction of stress",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Short-term reduction of appetite",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Shepard RJ, Balady GJ. Circulation 1999; 99:963.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_50_39723=[""].join("\n");
var outline_f38_50_39723=null;
var title_f38_50_39724="Cell associated pattern recognition receptors";
var content_f38_50_39724=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F66228&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F66228&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major PRRs: Cell-associated",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        PRR",
"       </td>",
"       <td class=\"subtitle1\">",
"        Recognize",
"       </td>",
"       <td class=\"subtitle1\">",
"        Functions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Plasma membrane-bound",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Toll-like receptors (TLRs) 1,2,4,5,6",
"       </td>",
"       <td>",
"        Variety of microbial PAMPs",
"       </td>",
"       <td>",
"        Cytokine release, activation of immune cells",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Macrophage scavenger receptor",
"       </td>",
"       <td>",
"        Gram-negative and Gram-positive bacteria",
"       </td>",
"       <td>",
"        Cytokine release, activation of immune cells",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Macrophage mannose receptor",
"       </td>",
"       <td>",
"        Microbial mannan",
"       </td>",
"       <td>",
"        Opsonization of bacteria, fungi",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dectin-1",
"       </td>",
"       <td>",
"        Fungal &beta;-glucan",
"       </td>",
"       <td>",
"        Opsonization of bacteria, fungi",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Formyl peptide receptor",
"       </td>",
"       <td>",
"        Bacterial membrane N-formylmethionine",
"       </td>",
"       <td>",
"        Opsonization and microbial lysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Intracellular (cytoplasmic or endolysosomal)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        TLRs 3,7,8,9,10",
"       </td>",
"       <td>",
"        Variety of microbial PAMPs",
"       </td>",
"       <td>",
"        Cytokine release, activation of immune cells",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        NOD-like receptors (NLRs) (NOD1 and 2)",
"       </td>",
"       <td>",
"        Bacterial cell wall peptidoglycan, MDP",
"       </td>",
"       <td>",
"        Cytokine release, immune cell activation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        RIG-I-like receptors (RLRs) (RIG-I)",
"       </td>",
"       <td>",
"        Viral dsRNA",
"       </td>",
"       <td>",
"        Clearance of RNA and DNA viruses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        MDA5",
"       </td>",
"       <td>",
"        Viral dsRNA",
"       </td>",
"       <td>",
"        Clearance of RNA viruses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        LGP2",
"       </td>",
"       <td>",
"        Viral RNA",
"       </td>",
"       <td>",
"        Clearance of RNA viruses",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Additional plasma membrane receptors that typically do not react directly with microbes but play an important role in innate host defense are the complement receptors that bind activated (cleaved) C3 (C3b and C3bi), which mediate opsonization, and the macrophage receptor for phosphatidyl serine, which aids recovery from inflammation by removing apoptotic cells. Complement receptor 3 (CR3) can bind &beta;-glucan in fungal cell wall at a site distinct from its complement-binding site, but the biologic significance of this binding is not yet proven.",
"    <div class=\"footnotes\">",
"     ds: double-stranded; LGP2: laboratory of genetics and physiology 2; MDA5: melanoma differentiation-associated gene 5; NOD: nucleotide-binding oligomerization domain; RIG-I: retinoic acid-inducible gene I.",
"    </div>",
"    <div class=\"reference\">",
"     Original figure modified for this publication. Reproduced from: Liu, AH, Zasloff, MA, Johnston, RB Jr. Innate immunity. In: Middleton's Allergy: Principles and Practice, 7th ed, Adkinson, NF Jr, Busse, WW, Bochner, BS, et al (Eds), Elsevier 2008. Illustration used with the permission of Elsevier, Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_50_39724=[""].join("\n");
var outline_f38_50_39724=null;
var title_f38_50_39725="Afterload and cardiac output";
var content_f38_50_39725=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F55742&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F55742&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Effect of increasing afterload on cardiac function",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 342px; height: 240px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Curves relating stroke volume or cardiac to afterload or systemic vascular resistance (SVR) in normal subjects and those with heart failure and increasing degrees of ventricular dysfunction. Increasing afterload has little acute effect in normal subjects but becomes progressively more limiting on cardiac output in HF. Even though the effect is small with mild HF, lowering afterload is still important over the long-term because it slows the rate of loss of myocardial function.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_50_39725=[""].join("\n");
var outline_f38_50_39725=null;
var title_f38_50_39726="HDV HBV reinfxn in liver TPL";
var content_f38_50_39726=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F74844&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F74844&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 541px\">",
"   <div class=\"ttl\">",
"    Hepatitis D virus and hepatitis B virus reinfection after liver transplantation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 521px; height: 431px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A patient who underwent transplantation for HDV cirrhosis developed HBV recurrence at eight months. Acute hepatitis (AH) occurred two months later with expression of HDAg in the liver. Serum HDV-RNA became detectable at 13 months. The patient progressed to chronic active hepatitis (CAH) with persistence of detectable HBV and HDV replication seven years after grafting. ALT, alanine aminotransferases; hatched area, upper limit of normal for ALT.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Samuel, D, Zignego, AL, Reynes, M, et al, Hepatology 1995; 21:334.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_50_39726=[""].join("\n");
var outline_f38_50_39726=null;
var title_f38_50_39727="Contents: Pediatric cardiology";
var content_f38_50_39727=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?17/55/18302\">",
"       Pediatrics",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Pediatric cardiology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Pediatric cardiology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Anomalies of the great vessels",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/62/16362\">",
"           L-transposition of the great arteries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/59/36793\">",
"           Management and outcome of D-transposition of the great arteries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/8/25735\">",
"           Pathophysiology, clinical manifestations, and diagnosis of D-transposition of the great arteries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/47/2809\">",
"           Truncus arteriosus",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Aortic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/53/23385\">",
"           Clinical manifestations and diagnosis of coarctation of the aorta",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/3/20538\">",
"           Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/27/20922\">",
"           Management of coarctation of the aorta",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/62/1002\">",
"           Management of patent ductus arteriosus in premature infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/50/15145\">",
"           Pathophysiology, clinical manifestations, and diagnosis of patent ductus arteriosus in premature infants",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Arrhythmias",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/55/23418\">",
"           Acquired long QT syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/34/16937\">",
"           Atrial tachycardias in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/24/33161\">",
"           Bradycardia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/33/15897\">",
"           Causes of wide QRS complex tachycardia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/9/2202\">",
"           Clinical features of congenital long QT syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/6/33897\">",
"           Diagnosis of congenital long QT syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/0/28681\">",
"           Genetics of congenital and acquired long QT syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/38/43623\">",
"           Irregular heart rate (arrhythmias) in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/40/22152\">",
"           Management and evaluation of wide QRS complex tachycardia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/9/15514\">",
"           Management of supraventricular tachycardia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/23/9591\">",
"           Pathophysiology of the long QT syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/3/26682\">",
"           Prognosis and management of congenital long QT syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/54/31593\">",
"           Supraventricular tachycardia in children: AV reentrant tachycardia (including WPW) and AV nodal reentrant tachycardia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Assessment",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/38/27241\">",
"           Approach to chest pain in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/17/28948\">",
"           Assessment of perfusion in pediatric resuscitation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/39/34423\">",
"           Cardiac evaluation of patients receiving pharmacotherapy for attention deficit hyperactivity disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/7/12409\">",
"           Suspected heart disease in infants and children: Criteria for referral",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Atherosclerosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/17/281\">",
"           Definition and screening for dyslipidemia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/15/40184\">",
"           Diseases associated with atherosclerosis in childhood",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/25/37274\">",
"           Inherited disorders of LDL-cholesterol metabolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/63/12282\">",
"           Management of pediatric dyslipidemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/49/23320\">",
"           Overview of the management of the child at risk for atherosclerosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/48/25352\">",
"           Pediatric prevention of adult cardiovascular disease: Promoting a healthy lifestyle and identifying at-risk children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/5/43096\">",
"           Risk factors and development of atherosclerosis in childhood",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cardiac malformations",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/55/24442\">",
"           Pulmonary atresia with intact ventricular septum (PA/IVS)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Conduction abnormalities",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/57/24474\">",
"           Neonatal lupus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/45/39641\">",
"           Pregnancy in women with systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/23/8568\">",
"           The anti-Ro/SSA and anti-La/SSB antigen-antibody systems",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Congenital heart disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/56/20359\">",
"           Cardiac causes of cyanosis in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/37/26201\">",
"           Classification and clinical features of isolated atrial septal defects in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/53/23385\">",
"           Clinical manifestations and diagnosis of coarctation of the aorta",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/52/35656\">",
"           Clinical manifestations and diagnosis of patent ductus arteriosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/34/11818\">",
"           Clinical manifestations, pathophysiology, and diagnosis of atrioventricular (AV) canal defects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/56/14218\">",
"           Congenital and pediatric coronary artery abnormalities",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/44/33482\">",
"           Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/62/36837\">",
"           Devices for percutaneous closure of a secundum atrial septal defect",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/2/43048\">",
"           Diagnosis and initial management of cyanotic heart disease in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/1/3096\">",
"           Echocardiographic evaluation of ventricular septal defects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/55/6007\">",
"           Evaluation and prognosis of Eisenmenger syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/27/41401\">",
"           Hypoplastic left heart syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/3/48\">",
"           Management and outcome of atrioventricular (AV) canal defects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/1/38936\">",
"           Management and outcome of isolated atrial septal defects in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/27/20922\">",
"           Management of coarctation of the aorta",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/55/34680\">",
"           Management of isolated ventricular septal defects in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/42/33448\">",
"           Management of patent ductus arteriosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/62/1002\">",
"           Management of patent ductus arteriosus in premature infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/7/28794\">",
"           Overview of the management of tetralogy of Fallot",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/36/3656\">",
"           Partial anomalous pulmonary venous connection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/19/8506\">",
"           Pathophysiology and clinical features of isolated ventricular septal defects in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/15/4344\">",
"           Pathophysiology of left to right shunts",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/27/13752\">",
"           Pathophysiology, clinical features, and diagnosis of tetralogy of Fallot",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/50/15145\">",
"           Pathophysiology, clinical manifestations, and diagnosis of patent ductus arteriosus in premature infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/7/29818\">",
"           Pregnancy in women with congenital heart disease: General principles",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/21/35159\">",
"           Pregnancy in women with congenital heart disease: Specific lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/52/40774\">",
"           Supravalvar aortic stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/51/10040\">",
"           Total anomalous pulmonary venous connection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/5/27735\">",
"           Vascular rings",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Endocardial and myocardial disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/53/34647\">",
"           Clinical manifestations and diagnosis of myocarditis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/15/27896\">",
"           Infective endocarditis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/37/2647\">",
"           Treatment and prognosis of myocarditis in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Heart failure",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/15/9466\">",
"           Etiology and diagnosis of heart failure in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/16/5386\">",
"           Management of heart failure in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/0/39945\">",
"           Sudden cardiac arrest and death in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypertension",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/45/17113\">",
"           Definition and diagnosis of hypertension in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/60/37833\">",
"           Etiology, clinical features, and diagnosis of neonatal hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/59/42936\">",
"           Management of hypertension in infants",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pericardial disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/3/29752\">",
"           Differentiating constrictive pericarditis and restrictive cardiomyopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/7/23669\">",
"           Electrocardiogram in pericarditis and pericardial effusion",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/24/6533\">",
"           Pericarditis in renal failure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/57/11158\">",
"           Pulsus paradoxus in pericardial disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/30/35303\">",
"           Purulent pericarditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/58/11177\">",
"           Recurrent pericarditis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pregnancy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/45/39641\">",
"           Pregnancy in women with systemic lupus erythematosus",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Resuscitation",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/43/7864\">",
"           Basic life support in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/23/15738\">",
"           Primary drugs in pediatric resuscitation",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Systemic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/46/41706\">",
"           Cardiotoxicity of anthracycline-like chemotherapy agents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/6/30826\">",
"           Cardiovascular sequelae of Kawasaki disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/20/23879\">",
"           Clinical manifestations and diagnosis of acute rheumatic fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/8/8327\">",
"           Epidemiology and pathogenesis of acute rheumatic fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/45/39641\">",
"           Pregnancy in women with systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/2/44070\">",
"           Treatment and prevention of acute rheumatic fever",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Valvular disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/33/1559\">",
"           Aortic regurgitation in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/25/27032\">",
"           Pregnancy in women with a bicuspid aortic valve",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/27/33207\">",
"           Subvalvar aortic stenosis (subaortic stenosis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/52/40774\">",
"           Supravalvar aortic stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/28/38345\">",
"           Valvar aortic stenosis in children",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-83D2A9476A-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f38_50_39727=[""].join("\n");
var outline_f38_50_39727=null;
